Any and all applications for which a domestic priority claim is identified in the Application Data Sheet of the present application are hereby incorporated by reference under 37 CFR 1.57.
This disclosure in part describes embodiments of non-invasive methods, devices, and systems for measuring a blood analyte, such as oxygen, carbon monoxide, methemoglobin, total hemoglobin, glucose, proteins, lipids, a percentage thereof (for example, saturation) or for measuring many other physiologically relevant patient characteristics. These characteristics can relate, for example, to pulse rate, hydration, trending information and analysis, and the like. In certain embodiments, a non-invasive sensor can interface with tissue at a measurement site, irradiate the tissue, and detect optical radiation after attenuation by the tissue.
This disclosure in part also describes embodiments of a semiconductor device, such as a photodiode, for detecting optical radiation at both visible and near-infrared wavelengths. The semiconductor device can, for example, be used as part of a non-invasive sensor to detect visible and near-infrared wavelengths of optical radiation after attenuation by tissue.
Because individual detectors (for example, individual photodiodes) of non-invasive sensors may be responsive to a limited range of wavelengths of optical radiation, multiple detectors may be used in combination, in some instances, to construct a non-invasive sensor that detects optical radiation at a broad range of wavelengths of optical radiation. For example, it is common to use both an InGaAs photodiode in combination with a Si photodiode in order to measure a broader range of wavelengths. However, each additional detector included in a non-invasive sensor can utilize additional space within the sensor and cause the sensor to be larger or more complicated to assemble. Also, having two sensors at two different positions can affect the optical radiation path length of the respective detected optical radiation of each detector. This inherently introduces inaccuracies and may require, for instance, some post-processing compensation to account for the inaccuracies. Moreover, each additional detector can consume space that may be used in another way, such as to increase the size of one or more other detectors so that a stronger signal may be obtained.
In some embodiments, a photodiode is disclosed herein that can detect optical radiation at a broad range of wavelengths obviating the necessity for two separate photodiodes as was previously utilized. The photodiode can be part of an integrated semiconductor structure that can generate a detector signal responsive to optical radiation at both visible and infrared wavelengths incident on the photodiode. The photodiode can include a window layer that forms part of an external surface of the photodiode. The external surface may be disposed to receive the optical radiation incident on the photodiode and pass the optical radiation to other layers of the photodiode. Advantageously, in certain embodiments, the thickness of the window layer can be minimized or the bandgap of the window layer can be maximized, or both, to increase the transmittance of the window layer for certain wavelengths of optical radiation and thus the responsiveness of photodiode to the certain wavelengths of optical radiation. For example, in one implementation, the photodiode can be an InGaAs photodiode with the window layer having a composition of InAlAs and a relatively thin thickness; this implementation can notably result in a high transmittance of optical radiation both in the near-infrared wavelengths and visible wavelengths.
The photodiode of the preceding paragraph can be used, for example, as a detector in a non-invasive sensor. In addition, advantageously, the photodiode of the preceding paragraph can enable a non-invasive sensor to be constructed which has fewer detectors because the photodiode may serve to detect optical radiation at wavelengths traditionally detected using two or more separate detectors. For example, when the photodiode may be an enhanced InGaAs photodiode, as described herein, with a window layer having a InAlAs composition and a relatively thin thickness, the photodiode can enable the non-invasive sensor to detect optical radiation traditionally detected using one Si photodiode and one traditional InGaAs photodiode with a window layer having a InP composition and a relatively thicker thickness of about 500 nm. As a result, the non-invasive sensor constructed in accordance with the teachings of this disclosure may include fewer detectors or the size of one or more of the detectors can be increased so that the one or more detectors provide greater signal strength. In one example, the surface area covered by the enhanced InGaAs photodiode within the non-invasive sensor can be doubled because the Si photodiode may not be included within the non-invasive sensor, thereby allowing the signal strength of a detector signal output by the enhanced InGaAs photodiode to be doubled over that of the traditional InGaAs photodiode when combined with the Si photodiode.
As used herein, optical radiation at visible wavelengths, in addition to having its ordinary meaning, can refer to optical radiation in the visible spectrum ranging from about 380 nm to about 750 nm. Additionally, as used herein, optical radiation at near-infrared wavelengths, in addition to having its ordinary meaning, can refer to optical radiation in the near-infrared spectrum ranging from about 750 nm to about 1700 nm.
For purposes of summarizing the disclosure, certain aspects, advantages and novel features have been described herein. It is to be understood that not necessarily all such advantages can be achieved in accordance with any particular embodiment. Thus, the embodiments can be embodied or carried out in a manner that achieves or optimizes one advantage or group of advantages as taught herein without necessarily achieving other advantages as can be taught or suggested herein.
The data collection system 100 can measure analyte concentrations, including glucose, at least in part by detecting optical radiation attenuated by a measurement site 102. The measurement site 102 can be any location on a patient's body, such as a finger, foot, ear lobe, or the like. For convenience, this disclosure is described primarily in the context of a finger measurement site 102. However, the features of the embodiments disclosed herein can be used with other measurement sites 102.
In the depicted embodiment, the data collection system 100 includes an optional tissue thickness adjuster or tissue shaper 105, which can include one or more protrusions, bumps, lenses, or other suitable tissue-shaping mechanisms. In certain embodiments, the tissue shaper 105 is a flat or substantially flat surface that can be positioned proximate the measurement site 102 and that can apply sufficient pressure to cause the tissue of the measurement site 102 to be flat or substantially flat. In other embodiments, the tissue shaper 105 is a convex or substantially convex surface with respect to the measurement site 102.
The data collection system 100 shown also includes an optional noise shield 103. The noise shield 103 can be adapted to reduce electromagnetic noise while increasing the transmittance of optical radiation from the measurement site 102 to one or more detectors 106. For example, the noise shield 103 can advantageously include a conductive coated glass or metal grid electrically communicating with one or more other shields of the sensor 101 or electrically grounded.
The measurement site 102 can be located somewhere along a non-dominant arm or a non-dominant hand, e.g., a right-handed person's left arm or left hand. In some patients, the non-dominant arm or hand can have less musculature and higher fat content, which can result in less water content in that tissue of the patient. Tissue having less water content can provide less interference with the particular wavelengths that are absorbed in a useful manner by blood analytes like glucose. Accordingly, in some embodiments, the data collection system 100 can be used on a person's non-dominant hand or arm.
The data collection system 100 can include a sensor 101 (or multiple sensors) that is coupled to a processing device or physiological monitor 109. In some implementations, the sensor 101 and the monitor 109 can be integrated together into a single unit. In other implementations, the sensor 101 and the monitor 109 can be separate from each other and communicate one with another in any suitable manner, such as via a wired or wireless connection. The sensor 101 and monitor 109 can be attachable and detachable from each other for the convenience of the user or caregiver, for ease of storage, sterility issues, or the like. The sensor 101 and the monitor 109 will now be further described.
In the depicted embodiment shown in
In some embodiments, the emitter 104 is used as a point optical source, and thus, the one or more optical sources of the emitter 104 can be located within a close distance to each other, such as within about a 2 mm to about 4 mm. The emitter 104 can be arranged in an array, such as is described in U.S. Patent Application Publication No. 2006/0211924, filed Sep. 21, 2006, titled “Multiple Wavelength Sensor Emitters,” the disclosure of which is hereby incorporated by reference in its entirety. In particular, the emitter 104 can be arranged at least in part as described in paragraphs [0061] through [0068] of the aforementioned publication, which paragraphs are hereby incorporated specifically by reference. Other relative spatial relationships can be used to arrange the emitter 104.
The emitter 104 of the data collection system 100 can emit, for example, combinations of optical radiation in various bands of interest. For instance, for analytes like glucose, the emitter 104 can emit optical radiation at three (3) or more wavelengths between about 1600 nm to about 1700 nm. Measurements at these wavelengths can be advantageously used to compensate or confirm the contribution of protein, water, and other non-hemoglobin species exhibited in measurements for analytes like glucose conducted between about 1600 nm and about 1700 nm. Of course, other wavelengths and combinations of wavelengths can be used to measure analytes or to distinguish other types of tissue, fluids, tissue properties, fluid properties, combinations of the same or the like.
The emitter 104 can emit optical radiation across other spectra for other analytes. In particular, the emitter 104 can employ optical radiation wavelengths to measure various blood analytes or percentages (e.g., saturation) thereof. For instance, the emitter 104 can emit optical radiation in the form of pulses at wavelengths about 905 nm, about 1050 nm, about 1200 nm, about 1300 nm, about 1330 nm, about 1610 nm, about 1640 nm, and about 1665 nm. In another embodiment, the emitter 104 can emit optical radiation ranging from about 860 nm to about 950 nm, about 950 nm to about 1100 nm, about 1100 nm to about 1270 nm, about 1250 nm to about 1350 nm, about 1300 nm to about 1360 nm, and about 1590 nm to about 1700 nm. Of course, the emitter 104 can transmit any of a variety of wavelengths of visible or near-infrared optical radiation.
The data collection system 100 also includes a driver 111 that drives the emitter 104. The driver 111 can be a circuit or the like that is controlled by the monitor 109. For example, the driver 111 can provide pulses of current to the emitter 104. In an embodiment, the driver 111 drives the emitter 104 in a progressive fashion, such as in an alternating manner. The driver 111 can drive the emitter 104 with a series of pulses of about 1 milliwatt (mW) for some wavelengths that can penetrate tissue relatively well and from about 40 mW to about 100 mW for other wavelengths that tend to be significantly absorbed in tissue. A wide variety of other driving powers and driving methodologies can be used in various embodiments.
The detectors 106 can capture and measure optical radiation from the measurement site 102. For example, the detectors 106 can capture and measure optical radiation transmitted from the emitter 104 that has been attenuated or reflected from the tissue in the measurement site 102. The detectors 106 can output a detector signal 107 responsive to the optical radiation captured or measured. The detectors 106 can be implemented using one or more photodiodes, phototransistors, or the like. Although the detectors 106 may be described as multiple detectors, in certain embodiments, the detectors 106 instead can be a single detector.
In one implementation, the detectors 106 can include one or more photodiodes, such as at least one of the photodiodes described with respect to
One or more photodiodes of the detectors 106 can be defined in terms of area. In an embodiment, the area of one photodiode can be from about 1 mm2-5 mm2 (or higher) and capable of generating about 100 nanoamps (nA) or less of current resulting from measured optical radiation at full scale. In addition to having its ordinary meaning, the phrase “at full scale” can mean optical radiation saturation of a photodiode amplifier (not shown). The data collection system 100 can, for instance, measure from one photodiode an output current range of approximately about 2 nA to about 100 nA or more full scale. Various other sizes and types of photodiodes can be used with the embodiments of the present disclosure.
The detectors 106 can be arranged with different spatial configurations, such as to provide or not provide a variation of path lengths among at least some of the detectors 106. Some of the detectors 106 can have substantially, or from the perspective of the processing algorithm, effectively, the same path length from the emitter 104. In one example, the detectors 106 can be arranged as is described in U.S. Patent Application Publication No. 2010/0026995, filed Aug. 3, 2009, titled “Multi-stream Sensor for Noninvasive Measurement of Blood Constituents,” the disclosure of which is hereby incorporated by reference in its entirety. In particular, the detectors can be arranged at least in part as described with respect to
The front-end interface 108 provides an interface that adapts the output of the detectors 106, which is responsive to desired physiological parameters. For example, the front-end interface 108 can adapt a signal 107 received from one or more of the detectors 106 into a form that can be processed by the monitor 109, for example, by a signal processor 110 in the monitor 109. The front-end interface 108 can also amplify current from the detectors 106 at desired signal-to-noise ratios (SNRs), such as to a SNR about 80 decibels (dB), 100 dB, or 120 dB in order to measure various desired analytes. The front-end interface 108 can have its components assembled in the sensor 101, in the monitor 109, in connecting cabling (if used), combinations of the same, or the like. The location of the front-end interface 108 can be chosen based on various factors including space desired for components, desired noise reductions or limits, desired heat reductions or limits, and the like.
The front-end interface 108 can be coupled to the detectors 106 and to the signal processor 110 using a bus, wire, electrical or optical cable, flex circuit, or some other form of signal connection. The front-end interface 108 can also be at least partially integrated with various components, such as the detectors 106. For example, the front-end interface 108 can include one or more integrated circuits that are on the same circuit board as the detectors 106. Other configurations can also be used.
The front-end interface 108 can be implemented using one or more amplifiers, such as transimpedance amplifiers, that are coupled to one or more analog to digital converters (ADCs) (which can be in the monitor 109), such as a sigma-delta ADC. A transimpedance-based front-end interface 108 can employ single-ended circuitry, differential circuitry, or a hybrid configuration. A transimpedance-based front-end interface 108 can be useful for its sampling rate capability and freedom in modulation/demodulation algorithms. For example, this type of front-end interface 108 can advantageously facilitate the sampling of the ADCs being synchronized with the pulses emitted from the emitter 104.
The ADC or ADCs can provide one or more outputs into multiple channels of digital information for processing by the signal processor 110 of the monitor 109. Each channel can correspond to a signal output from a detector 106.
As shown in
The signal processor 110 can provide various signals that control the operation of the sensor 101. For example, the signal processor 110 can provide an emitter control signal to the driver 111. This control signal can be useful in order to synchronize, minimize, or reduce jitter in the timing of pulses emitted from the emitter 104. Accordingly, this control signal can be useful in order to cause optical radiation pulses emitted from the emitter 104 to follow a precise timing and consistent pattern. As also shown, an optional memory 113 can be included in the front-end interface 108 or in the signal processor 110. This memory 113 can serve as a buffer or storage location for the front-end interface 108 or the signal processor 110, among other uses.
The user interface 112 can provide an output, for example, on a display, for presentation to a user of the data collection system 100. The user interface 112 can be implemented as a touch-screen display, an LCD display, an organic LED display, or the like. In addition, the user interface 112 can be manipulated to allow for measurement on the non-dominant side of patient. For example, the user interface 112 can include a flip screen, a screen that can be moved from one side to another on the monitor 109, or can include an ability to reorient its display indicia responsive to user input or device orientation. In alternative embodiments, the data collection system 100 can be provided without a user interface 112 and can simply provide an output signal to a separate display or system.
A storage device 114 and a network interface 116 represent other optional output connections that can be included in the monitor 109. The storage device 114 can include any computer-readable medium, such as a memory device, hard disk storage, EEPROM, flash drive, or the like. The various software or firmware applications can be stored in the storage device 114, which can be executed by the signal processor 110 or another processor of the monitor 109. The network interface 116 can be a serial bus port (RS-232/RS-485), a Universal Serial Bus (USB) port, an Ethernet port, a wireless interface (e.g., WiFi such as any 802.1x interface, including an internal wireless card), or other suitable communication device(s) that allows the monitor 109 to communicate and share data with other devices. The monitor 109 can also include various other components not shown, such as a microprocessor, graphics processor, or controller to output the user interface 112, to control data communications, to compute data trending, or to perform other operations.
Although not shown in the depicted embodiment, the data collection system 100 can include various other components or can be configured in different ways. For example, the sensor 101 can have both the emitter 104 and detectors 106 on the same side of the measurement site 102 and use reflectance to measure analytes. The data collection system 100 can also include a sensor that measures the power of optical radiation emitted from the emitter 104. Moreover, although the detectors 106 may be initially constructed to include one of the photodiodes described with respect to
At block 205, the emitter 104 can receive a drive signal from the driver 111. At block 210, the drive signal can cause the emitter 104 to irradiate tissue of a patient at wavelengths of visible optical radiation and near-infrared optical radiation. At block 215, a photodiode of the detectors 106 can detect the optical radiation after attenuation by the tissue. At block 220, the photodiode of the detectors 106 can generate one or more detector signals responsive to the detected optical radiation at the visible and near-infrared wavelengths. For instance, the photodiode can generate one signal responsive to the detected optical radiation at the visible wavelength and another signal responsive to the detected optical radiation at the near-infrared wavelength when the visible and near-infrared wavelengths are emitted at different times, or the photodiode can output can output a combined signal responsive to the detected optical radiation at the visible and near-infrared wavelengths when the visible and near-infrared wavelengths are emitted at substantially the same time. At block 225, the sensor 101 can output the one or more detector signals for processing by the signal processor 110 to determine measurement values for one or more physiological parameters of the patient.
In one implementation, the distal side metal contact 302 can be an n-type region contact and the proximal side metal contact 314 can be a p-type region contact. The semiconductor wafer 304 can, for instance, be an n-type InP wafer, which includes indium and phosphorous. The absorption region 306 can, for instance, be (i) an n-type or undoped InGaAs absorption region, which includes indium, gallium, and arsenic, (ii) an n-type or undoped InAlGaAs absorption region, which includes indium, aluminum, gallium, and arsenic, or (iii) an n-type or undoped InGaAsP region, which includes indium, gallium, arsenic, and phosphorous. The diffusion region 310 can, for instance, be a diffused region that turns n-type or undoped material into a p-type region to form a p-n semiconductor junction in selected areas defined by the diffusion mask 312. The diffusion mask 312 can, for instance, be a SiN or SiO2 diffusion mask. The photodiode, in one implementation, can accordingly be an InGaAs PIN photodiode.
The detector window layer 308 can be a layer that is sufficiently thin so that the detector window layer 308 passes visible optical radiation for detection by the photodiode and yet provides passivation of the absorption region 306 and the diffusion region 310, which can be a zinc-diffused P region, so that electron-hole pairs generated by the visible optical radiation, including short-wavelength optical radiation, near the surface of the photodiode (for example, in the P-region) have a lower recombination rate resulting in a quantum efficiency enhancement at visible wavelengths. For example, the detector window layer 308 can be a layer having a thickness of less than about 150 nm, such as a thickness ranging from about 25 nm to about 150 nm, from about 40 nm to about 130 nm, from about 50 nm to about 100 nm, or from about 45 nm to about 55 nm or a thickness of about 50 nm. Because the detector window layer 308 being thinner may result in more visible wavelengths passing into the photodiode, the detector window layer 308 can be desirably about 50 nm in certain implementations. The detector window layer 308 can be an epitaxially grown layer.
In one example, the detector window layer 308 can be an InP layer, which includes indium and phosphorous. The InP layer can have a bandgap of about 1.34 eV at 25° C. If the InP layer is about 400 nm thick, the external quantum efficiency at 660 nm can be about 8%. If the InP layer may be made thinner such as around 50 nm, the external quantum efficiency at 660 nm can be about 58%. Thinner layers, such as about window layers having a thickness of about 25 nm, can be made, but if made too thin, the microfabrication procedures used to make the photodiode may, in some instances, slightly etch or oxide the window layers, leaving no or minimal window layer so that the surface of the InGaAs or InAlGaAs photodiode may be unpassivated and have a lower quantum efficiency for visible wavelengths (for example, shorter wavelengths) due to enhanced recombination of photogenerated carriers in the layer at the unpassivated surface. There can thus exist an optimum InP layer thickness between 0 nm and about 50 nm for such devices, in particular implementations.
As another example, the detector window layer 308 can be an InAlAs layer, which includes indium, aluminum, and arsenic, which can either be of a composition whose atomic crystal lattice constant is lattice-matched or lattice mismatched to the absorption region 306 and semiconductor wafer 304. Advantageously, in certain embodiments, the InAlAs layer can be desirably thin to efficiently pass visible optical radiation for detection by the photodiode, similar to the InP layer example explained in the preceding paragraph. In one implementation, the InAlAs layer can be formed of a composition of In0.52Al0.48As that has a bandgap of about 1.52 eV at 25° C. and is lattice-matched to the semiconductor wafer 304. It has been determined that the In0.52Al0.48As layer can begin to strongly attenuate optical radiation at wavelengths shorter than about 817 nm as compared to an attenuation wavelength of about 920 nm at 25° C. for an InP layer and therefore can result in a relatively higher external quantum efficiency. In another implementation, the InAlAs layer can be formed of a composition of In0.46Al0.54As that has a larger bandgap of about 1.68 eV and is not lattice-matched to the semiconductor wafer 304. It has been determined that the In0.46Al0.54As layer can begin to strongly attenuate optical radiation at wavelengths shorter than about 739 nm and the external quantum efficiency for the photodiode with the In0.46Al0.54As layer may be about 78% at a wavelength about 660 nm. Because the detector window layer 308 having a higher bandgap can result in more visible optical radiation passing into the photodiode, the detector window layer 308 can be desirably composed of In0.46Al0.54As in certain implementations. Although the InAlAs composition may be lattice-mismatched to the crystal lattice constant of one or more of the underlying layers, is the layer can be generally sufficiently thin so that the layer may be strained to fit on the underlying crystal lattice without generation of dislocation defects, a condition that can be known as pseudomorphic growth. The following Table 1 summarizes some measured data for the above-referenced window layers of a similar photodiode structure and compares them to a model result for a photodiode structure with a window layer composed of InP with a thickness of 400 nm.
The curve 402 depicts a model relationship between external quantum efficiency versus optical radiation wavelength for a traditional photodiode formed from the semiconductor device 300 where the absorption region 306 is an n-type InAlGaAs absorption region and the detector window layer 308 has a thickness of about 400 nm and is an InP layer. The curve 404 depicts the measured relationship between external quantum efficiency versus optical radiation wavelength for a photodiode formed from the semiconductor device 300 where the absorption region 306 is an n-type InAlGaAs absorption region and the detector window layer 308 has a thickness of about 50 nm and is an InP layer. The curve 406 depicts the measured relationship between external quantum efficiency versus optical radiation wavelength for a photodiode formed from the semiconductor device 300 where the absorption region 306 is an n-type InAlGaAs absorption region and the detector window layer 308 has a thickness of about 50 nm and is a lattice-mismatched In0.46Al0.54As layer.
As can be seen from curves 404 and 406 of the graph 400, the quantum efficiency of an enhanced photodiode constructed in accordance with teachings of this disclosure can notably have an external quantum efficiency of greater than about 30% (such as an external quantum efficiency ranging from about 30% to about 90%, from about 50% to about 85%, or from about 60% to about 80% or an external quantum efficiency of about 50%, about 60%, about 70%, about 80% or about 90%) at wavelengths ranging from about 450 nm to 850 nm. Such an enhanced photodiode can accordingly be used, for instance, to detect optical radiation at wavelengths ranging from about 450 nm to about 850 nm, as well as from about 850 nm to about 1400 nm or 1430 nm.
Although the curves 402, 404, and 406 depict the quantum efficiency versus optical radiation wavelength for a photodiode where the absorption region 306 is an n-type InAlGaAs absorption region, the absorption region 306 may in some cases instead be an n-type InGaAs absorption region as mentioned previously. If the curves 402, 404, and 406 were depicted for photodiodes including the n-type InGaAs absorption region, the responsiveness of the photodiodes would further extend to about 1700 nm rather than about 1430 nm as illustrated in the graph 400. Therefore, in such implementations, an enhanced photodiode can be used, for instance, to detect optical radiation at wavelengths ranging from about 450 nm to about 850 nm, as well as from about 850 nm to about 1700 nm. In such implementations, the enhanced photodiode can, for instance, have an external quantum efficiency of greater than about 70% (such as an external quantum efficiency ranging from about 70% to about 95%, from about 80% to about 95%, from about 85% to about 95%, or from about 90% to about 95% or an external quantum efficiency of about 70%, about 80%, about 85%, about 90%, or about 95%) at wavelengths ranging from about 1400 nm to 1700 nm.
As illustrated by the graph 400, an enhanced photodiode having the performance characteristics of the curve 404 can have an external quantum efficiency of about 9% at 400 nm, 28% at 450 nm, 41% at 500 nm, 49% at 550 nm, 52% at 600 nm, 55% at 650 nm, 58% at 700 nm, 62% at 750 nm, 65% at 800 nm, 71% at 850 nm, 75% at 900 nm, 82% at 950 nm, 85% at 1000 nm, 89% at 1050 nm, 89% at 1100 nm, 92% at 1150 nm, 92% at 1200 nm, 92% at 1250 nm, 92% at 1300 nm, 92% at 1350 nm, 85% at 1400 nm, and 5% at 1450 nm. In addition, as illustrated by the graph 400, an enhanced photodiode having the performance characteristics of the curve 406 can have an external quantum efficiency of about 12% at 400 nm, 40% at 450 nm, 65% at 500 nm, 75% at 550 nm, 77% at 600 nm, 78% at 650 nm, 80% at 700 nm, 82% at 750 nm, 86% at 800 nm, 88% at 850 nm, 90% at 900 nm, 91% at 950 nm, 92% at 1000 nm, 94% at 1050 nm, 93% at 1100 nm, 96% at 1150 nm, 96% at 1200 nm, 95% at 1250 nm, 94% at 1300 nm, 92% at 1350 nm, 85% at 1400 nm, and 10% at 1450 nm. Moreover, an enhanced photodiode constructed in accordance with the teachings of this disclosure can thus have an external quantum efficiency of at least the external quantum efficiency of the curve 404 or the curve 406 at the various wavelengths illustrated in
As illustrated by the graph 400, an enhanced photodiode constructed in accordance with the teachings of this disclosure can have an external quantum efficiency ranging at least from about 9% to 12% at 400 nm, 28% to 40% at 450 nm, 41% to 65% at 500 nm, 49% to 75% at 550 nm, 52% to 77% at 600 nm, 55% to 78% at 650 nm, 58% to 80% at 700 nm, 62% to 82% at 750 nm, 65% to 86% at 800 nm, 71% to 88% at 850 nm, 75% to 90% at 900 nm, 82% to 91% at 950 nm, 85% to 92% at 1000 nm, 89% to 94% at 1050 nm, 89% to 93% at 1100 nm, 92% to 96% at 1150 nm, 92% to 96% at 1200 nm, 92% to 95% at 1250 nm, 92% to 94% at 1300 nm, 92% to 92% at 1350 nm, 85% to 85% at 1400 nm, and 5% to 10% at 1450 nm.
In some embodiments, when a photodiode has an external quantum efficiency at a particular wavelength that is below a threshold quantum efficiency level, an output current generated by the photodiode when irradiated by photons of the particular wavelength can be sufficiently low such that the photodiode may be considered to not detect the particular wavelength. This can, in some instances, be because the output current generated by the photodiode when irradiated by photons of the particular wavelength may be insufficient for use in confidently determining that the photodiode detected the particular wavelength. The threshold quantum efficiency level can vary, in certain embodiments, based at least on a system design in which the photodiode is used. For example, in certain medical device applications, such as in some example non-invasive sensor detector applications, the threshold quantum efficiency level can be about 30%, about 25%, about 20%, about 15%, or about 10%, such that when a photodiode detects particular wavelengths for which the photodiode has an external quantum efficiency below the threshold quantum efficiency level, the output current provided by the photodiode may be insufficient for the non-invasive sensor to confidently determine that the photodiode detected the particular wavelengths. Accordingly, in some instances, the photodiode may not be used to detect wavelengths for which the photodiode has an external quantum efficiency below the threshold quantum efficiency level, or the output current from the photodiode may be discarded as not providing usable information or information of sufficient quality if the output current is below a threshold current corresponding to the threshold quantum efficiency level.
Moreover, although some applications of the photodiode of the semiconductor device 300 are described in the context of a non-invasive sensor, the photodiode can be useful in numerous other applications. For example, the photodiode can be part of a spectrometer in industrial or manufacturing applications (for instance, in applications related to plastics, petroleum, chemical, or the like) and used to detect a broad range of electromagnetic radiation for detecting a spectrum of electromagnetic radiation. As another example, the photodiode can be part of a non-contact temperature measurement system and used to detect a broad range of electromagnetic radiation to determine a detected temperature. As a further example, the photodiode can be part of a flame monitoring or control system and used to detect one or more characteristics of a flame from the detected broad spectrum of electromagnetic radiation. Moreover, the photodiode can be part of a diode laser monitoring system (for instance, for telecommunications or lidar applications) and used to detect a broad range of electromagnetic radiation from one or more lasers.
Many other variations than those described herein will be apparent from this disclosure. For example, depending on the embodiment, certain acts, events, or functions of any of the algorithms described herein can be performed in a different sequence, can be added, merged, or left out altogether (e.g., not all described acts or events are necessary for the practice of the algorithms). Moreover, in certain embodiments, acts or events can be performed concurrently, e.g., through multi-threaded processing, interrupt processing, or multiple processors or processor cores or on other parallel architectures, rather than sequentially. In addition, different tasks or processes can be performed by different machines or computing systems that can function together.
The various illustrative logical blocks, modules, and algorithm steps described in connection with the embodiments disclosed herein can be implemented as electronic hardware, computer software, or combinations of both. To clearly illustrate this interchangeability of hardware and software, various illustrative components, blocks, modules, and steps have been described above generally in terms of their functionality. Whether such functionality is implemented as hardware or software depends upon the particular application and design constraints imposed on the overall system. The described functionality can be implemented in varying ways for each particular application, but such implementation decisions should not be interpreted as causing a departure from the scope of the disclosure.
The various illustrative logical blocks and modules described in connection with the embodiments disclosed herein can be implemented or performed by a machine, such as a general purpose processor, a digital signal processor (DSP), an application specific integrated circuit (ASIC), a field programmable gate array (FPGA) or other programmable logic device, discrete gate or transistor logic, discrete hardware components, or any combination thereof designed to perform the functions described herein. A general purpose processor can be a microprocessor, but in the alternative, the processor can be a controller, microcontroller, or state machine, combinations of the same, or the like. A processor can include electrical circuitry configured to process computer-executable instructions. In another embodiment, a processor includes an FPGA or other programmable device that performs logic operations without processing computer-executable instructions. A processor can also be implemented as a combination of computing devices, e.g., a combination of a DSP and a microprocessor, a plurality of microprocessors, one or more microprocessors in conjunction with a DSP core, or any other such configuration. A computing environment can include any type of computer system, including, but not limited to, a computer system based on a microprocessor, a mainframe computer, a digital signal processor, a portable computing device, a device controller, or a computational engine within an appliance, to name a few.
The steps of a method, process, or algorithm described in connection with the embodiments disclosed herein can be embodied directly in hardware, in a software module stored in one or more memory devices and executed by one or more processors, or in a combination of the two. A software module can reside in RAM memory, flash memory, ROM memory, EPROM memory, EEPROM memory, registers, hard disk, a removable disk, a CD-ROM, or any other form of non-transitory computer-readable storage medium, media, or physical computer storage known in the art. An example storage medium can be coupled to the processor such that the processor can read information from, and write information to, the storage medium. In the alternative, the storage medium can be integral to the processor. The storage medium can be volatile or nonvolatile. The processor and the storage medium can reside in an ASIC.
Conditional language used herein, such as, among others, “can,” “might,” “may,” “e.g.,” and the like, unless specifically stated otherwise, or otherwise understood within the context as used, is generally intended to convey that certain embodiments include, while other embodiments do not include, certain features, elements or states. Thus, such conditional language is not generally intended to imply that features, elements or states are in any way required for one or more embodiments or that one or more embodiments necessarily include logic for deciding, with or without author input or prompting, whether these features, elements or states are included or are to be performed in any particular embodiment. The terms “comprising,” “including,” “having,” and the like are synonymous and are used inclusively, in an open-ended fashion, and do not exclude additional elements, features, acts, operations, and so forth. Also, the term “or” is used in its inclusive sense (and not in its exclusive sense) so that when used, for example, to connect a list of elements, the term “or” means one, some, or all of the elements in the list. Further, the term “each,” as used herein, in addition to having its ordinary meaning, can mean any subset of a set of elements to which the term “each” is applied.
Terms such as “substantially,” “about,” “approximately” or the like as used in referring to a relationship between two objects is intended to reflect not only an exact relationship but also variances in that relationship that may be due to various factors such as the effects of environmental conditions, common error tolerances, manufacturing variances, or the like. It should further be understood that although some values or other relationships may be expressed herein without a modifier, these values or other relationships may also be exact or may include a degree of variation due to various factors such as the effects of environmental conditions, common error tolerances, or the like. For example, when referring to wavelengths of electromagnetic radiation, about a specified wavelength can, in some contexts, refer to a wavelength variation of around less than 1% (such as a variation of 1%, 0.8%, 0.5%, or 0.3%) from the specified wavelength. Accordingly, an about 660 nm wavelength can refer to 660 nm±6 nm, 660 nm±5 nm, 660 nm±3 nm, or 660 nm±2 nm. As another example, when referring to a thickness of a layer, about a specified thickness can, in some contexts, refer to a thickness variation of around less than 5% (such as a variation of 5%, 3%, 2%, 1%, or 0.1%) from the specified thickness. Accordingly, an about 50 nm thickness can refer to 50 nm±2.5 nm, 50 nm±1.5 nm, 50 nm±1 nm, or 50 nm±0.5 nm, or 50 nm±0.05 nm. As a further example, when referring to an eV of a bandgap, about a specified eV can, in some contexts, refer to an eV variation of around less than 2% (such as a variation of 2%, 1.5%, 1%, or 0.5%) from the specified eV. Accordingly, an about 1.52 eV bandgap can refer to 1.52 eV±0.03 eV, 1.52 eV±0.023 eV, 1.52 eV±0.015 eV, or 1.52 eV±0.008 eV. In another example, when referring to an external quantum efficiency of a layer, about a specified external quantum efficiency percentage can, in some contexts, refer to an external quantum efficiency percentage variation of around less than 3% (such as a variation of 3%, 2%, 1%, or 0.5%) from the specified external quantum efficiency percentage. Accordingly, an about 58% external quantum efficiency can refer to 58%±3%, 58%±2%, 58%±1%, or 58%±0.5%.
Disjunctive language such as the phrase “at least one of X, Y and Z,” unless specifically stated otherwise, is to be understood with the context as used in general to convey that an item, term, etc. may be either X, Y, or Z, or a combination thereof. Thus, such conjunctive language is not generally intended to imply that certain embodiments require at least one of X, at least one of Y and at least one of Z to each be present.
Unless otherwise explicitly stated, articles such as “a” or “an” should generally be interpreted to include one or more described items. Accordingly, phrases such as “a device configured to” are intended to include one or more recited devices. Such one or more recited devices can also be collectively configured to carry out the stated recitations. For example, “a processor configured to carry out recitations A, B and C” can include a first processor configured to carry out recitation A working in conjunction with a second processor configured to carry out recitations B and C.
While the above detailed description has shown, described, and pointed out novel features as applied to various embodiments, it will be understood that various omissions, substitutions, and changes in the form and details of the devices or algorithms illustrated can be made without departing from the spirit of the disclosure. As will be recognized, certain embodiments described herein can be embodied within a form that does not provide all of the features and benefits set forth herein, as some features can be used or practiced separately from others.
Number | Name | Date | Kind |
---|---|---|---|
4960128 | Gordon et al. | Oct 1990 | A |
4964408 | Hink et al. | Oct 1990 | A |
5041187 | Hink et al. | Aug 1991 | A |
5069213 | Hink et al. | Dec 1991 | A |
5163438 | Gordon et al. | Nov 1992 | A |
5319355 | Russek | Jun 1994 | A |
5337744 | Branigan | Aug 1994 | A |
5341805 | Stavridi et al. | Aug 1994 | A |
D353195 | Savage et al. | Dec 1994 | S |
D353196 | Savage et al. | Dec 1994 | S |
5377676 | Vari et al. | Jan 1995 | A |
5412229 | Kuhara | May 1995 | A |
D359546 | Savage et al. | Jun 1995 | S |
5431170 | Mathews | Jul 1995 | A |
5436499 | Namavar et al. | Jul 1995 | A |
D361840 | Savage et al. | Aug 1995 | S |
D362063 | Savage et al. | Sep 1995 | S |
5452717 | Branigan et al. | Sep 1995 | A |
D363120 | Savage et al. | Oct 1995 | S |
5456252 | Vari et al. | Oct 1995 | A |
5479934 | Imran | Jan 1996 | A |
5482036 | Diab et al. | Jan 1996 | A |
5490505 | Diab et al. | Feb 1996 | A |
5494043 | O'Sullivan et al. | Feb 1996 | A |
5533511 | Kaspari et al. | Jul 1996 | A |
5534851 | Russek | Jul 1996 | A |
5561275 | Savage et al. | Oct 1996 | A |
5562002 | Lalin | Oct 1996 | A |
5590649 | Caro et al. | Jan 1997 | A |
5602924 | Durand et al. | Feb 1997 | A |
5632272 | Diab et al. | May 1997 | A |
5638816 | Kiani-Azarbayjany et al. | Jun 1997 | A |
5638818 | Diab et al. | Jun 1997 | A |
5645440 | Tobler et al. | Jul 1997 | A |
5671914 | Kalkhoran et al. | Sep 1997 | A |
5685299 | Diab et al. | Nov 1997 | A |
5726440 | Kalkhoran et al. | Mar 1998 | A |
D393830 | Tobler et al. | Apr 1998 | S |
5743262 | Lepper, Jr. et al. | Apr 1998 | A |
5747806 | Khalil et al. | May 1998 | A |
5750994 | Schlager | May 1998 | A |
5758644 | Diab et al. | Jun 1998 | A |
5760910 | Lepper, Jr. et al. | Jun 1998 | A |
5769785 | Diab et al. | Jun 1998 | A |
5782757 | Diab et al. | Jul 1998 | A |
5785659 | Caro et al. | Jul 1998 | A |
5791347 | Flaherty et al. | Aug 1998 | A |
5810734 | Caro et al. | Sep 1998 | A |
5823950 | Diab et al. | Oct 1998 | A |
5830131 | Caro et al. | Nov 1998 | A |
5833618 | Caro et al. | Nov 1998 | A |
5860919 | Kiani-Azarbayjany et al. | Jan 1999 | A |
5890929 | Mills et al. | Apr 1999 | A |
5904654 | Wohltmann et al. | May 1999 | A |
5919134 | Diab | Jul 1999 | A |
5934925 | Tobler et al. | Aug 1999 | A |
5940182 | Lepper, Jr. et al. | Aug 1999 | A |
5987343 | Kinast | Nov 1999 | A |
5995855 | Kiani et al. | Nov 1999 | A |
5997343 | Mills et al. | Dec 1999 | A |
6002952 | Diab et al. | Dec 1999 | A |
6010937 | Karam et al. | Jan 2000 | A |
6011986 | Diab et al. | Jan 2000 | A |
6027452 | Flaherty et al. | Feb 2000 | A |
6036642 | Diab et al. | Mar 2000 | A |
6040578 | Malin et al. | Mar 2000 | A |
6045509 | Caro et al. | Apr 2000 | A |
6066204 | Haven | May 2000 | A |
6067462 | Diab et al. | May 2000 | A |
6081735 | Diab et al. | Jun 2000 | A |
6088607 | Diab et al. | Jul 2000 | A |
6110522 | Lepper, Jr. et al. | Aug 2000 | A |
6110758 | Estrera | Aug 2000 | A |
6115673 | Malin et al. | Sep 2000 | A |
6124597 | Shehada et al. | Sep 2000 | A |
6128521 | Marro et al. | Oct 2000 | A |
6129675 | Jay | Oct 2000 | A |
6144868 | Parker | Nov 2000 | A |
6151516 | Kiani-Azarbayjany et al. | Nov 2000 | A |
6152754 | Gerhardt et al. | Nov 2000 | A |
6157850 | Diab et al. | Dec 2000 | A |
6165005 | Mills et al. | Dec 2000 | A |
6184521 | Coffin, IV et al. | Feb 2001 | B1 |
6206830 | Diab et al. | Mar 2001 | B1 |
6229856 | Diab et al. | May 2001 | B1 |
6232609 | Snyder et al. | May 2001 | B1 |
6236872 | Diab et al. | May 2001 | B1 |
6241683 | Macklem et al. | Jun 2001 | B1 |
6253097 | Aronow et al. | Jun 2001 | B1 |
6255708 | Sudharsanan et al. | Jul 2001 | B1 |
6256523 | Diab et al. | Jul 2001 | B1 |
6263222 | Diab et al. | Jul 2001 | B1 |
6278522 | Lepper, Jr. et al. | Aug 2001 | B1 |
6280213 | Tobler et al. | Aug 2001 | B1 |
6280381 | Malin et al. | Aug 2001 | B1 |
6285896 | Tobler et al. | Sep 2001 | B1 |
6301493 | Marro et al. | Oct 2001 | B1 |
6308089 | von der Ruhr et al. | Oct 2001 | B1 |
6317627 | Ennen et al. | Nov 2001 | B1 |
6321100 | Parker | Nov 2001 | B1 |
6325761 | Jay | Dec 2001 | B1 |
6334065 | Al-Ali et al. | Dec 2001 | B1 |
6343224 | Parker | Jan 2002 | B1 |
6349228 | Kiani et al. | Feb 2002 | B1 |
6360114 | Diab et al. | Mar 2002 | B1 |
6368283 | Xu et al. | Apr 2002 | B1 |
6371921 | Caro et al. | Apr 2002 | B1 |
6377829 | Al-Ali | Apr 2002 | B1 |
6388240 | Schulz et al. | May 2002 | B2 |
6397091 | Diab et al. | May 2002 | B2 |
6411373 | Garside et al. | Jun 2002 | B1 |
6415167 | Blank et al. | Jul 2002 | B1 |
6430437 | Marro | Aug 2002 | B1 |
6430525 | Weber et al. | Aug 2002 | B1 |
6463311 | Diab | Oct 2002 | B1 |
6470199 | Kopotic et al. | Oct 2002 | B1 |
6487429 | Hockersmith et al. | Nov 2002 | B2 |
6501975 | Diab et al. | Dec 2002 | B2 |
6505059 | Kollias et al. | Jan 2003 | B1 |
6515273 | Al-Ali | Feb 2003 | B2 |
6519487 | Parker | Feb 2003 | B1 |
6525386 | Mills et al. | Feb 2003 | B1 |
6526300 | Kiani et al. | Feb 2003 | B1 |
6534012 | Hazen et al. | Mar 2003 | B1 |
6541756 | Schulz et al. | Apr 2003 | B2 |
6542764 | Al-Ali et al. | Apr 2003 | B1 |
6580086 | Schulz et al. | Jun 2003 | B1 |
6584336 | Ali et al. | Jun 2003 | B1 |
6587196 | Stippick et al. | Jul 2003 | B1 |
6587199 | Luu | Jul 2003 | B1 |
6595316 | Cybulski et al. | Jul 2003 | B2 |
6597932 | Tian et al. | Jul 2003 | B2 |
6597933 | Kiani et al. | Jul 2003 | B2 |
6606511 | Ali et al. | Aug 2003 | B1 |
6632181 | Flaherty et al. | Oct 2003 | B2 |
6635559 | Greenwald et al. | Oct 2003 | B2 |
6639668 | Trepagnier | Oct 2003 | B1 |
6640116 | Diab | Oct 2003 | B2 |
6640117 | Makarewicz et al. | Oct 2003 | B2 |
6643530 | Diab et al. | Nov 2003 | B2 |
6650917 | Diab et al. | Nov 2003 | B2 |
6654624 | Diab et al. | Nov 2003 | B2 |
6658276 | Kiani et al. | Dec 2003 | B2 |
6661161 | Lanzo et al. | Dec 2003 | B1 |
6671531 | Al-Ali | Dec 2003 | B2 |
6678543 | Diab et al. | Jan 2004 | B2 |
6684090 | Ali et al. | Jan 2004 | B2 |
6684091 | Parker | Jan 2004 | B2 |
6697656 | Al-Ali | Feb 2004 | B1 |
6697657 | Shehada et al. | Feb 2004 | B1 |
6697658 | Al-Ali | Feb 2004 | B2 |
RE38476 | Diab et al. | Mar 2004 | E |
6699194 | Diab et al. | Mar 2004 | B1 |
6714804 | Al-Ali et al. | Mar 2004 | B2 |
RE38492 | Diab et al. | Apr 2004 | E |
6721582 | Trepagnier et al. | Apr 2004 | B2 |
6721585 | Parker | Apr 2004 | B1 |
6725075 | Al-Ali | Apr 2004 | B2 |
6728560 | Kollias et al. | Apr 2004 | B2 |
6735459 | Parker | May 2004 | B2 |
6738652 | Mattu et al. | May 2004 | B2 |
6745060 | Diab et al. | Jun 2004 | B2 |
6760607 | Al-Ali | Jul 2004 | B2 |
6770028 | Ali et al. | Aug 2004 | B1 |
6771994 | Kiani et al. | Aug 2004 | B2 |
6788965 | Ruchti et al. | Sep 2004 | B2 |
6792300 | Diab et al. | Sep 2004 | B1 |
6813511 | Diab et al. | Nov 2004 | B2 |
6816241 | Grubisic | Nov 2004 | B2 |
6816741 | Diab | Nov 2004 | B2 |
6822564 | Al-Ali | Nov 2004 | B2 |
6826419 | Diab et al. | Nov 2004 | B2 |
6830711 | Mills et al. | Dec 2004 | B2 |
6850787 | Weber et al. | Feb 2005 | B2 |
6850788 | Al-Ali | Feb 2005 | B2 |
6852083 | Caro et al. | Feb 2005 | B2 |
6861639 | Al-Ali | Mar 2005 | B2 |
6876931 | Lorenz et al. | Apr 2005 | B2 |
6898452 | Al-Ali et al. | May 2005 | B2 |
6920345 | Al-Ali et al. | Jul 2005 | B2 |
6931268 | Kiani-Azarbayjany et al. | Aug 2005 | B1 |
6934570 | Kiani et al. | Aug 2005 | B2 |
6939305 | Flaherty et al. | Sep 2005 | B2 |
6943348 | Coffin, IV | Sep 2005 | B1 |
6950687 | Al-Ali | Sep 2005 | B2 |
6956649 | Acosta et al. | Oct 2005 | B2 |
6961598 | Diab | Nov 2005 | B2 |
6970792 | Diab | Nov 2005 | B1 |
6979812 | Al-Ali | Dec 2005 | B2 |
6985764 | Mason et al. | Jan 2006 | B2 |
6990364 | Ruchti et al. | Jan 2006 | B2 |
6993371 | Kiani et al. | Jan 2006 | B2 |
6996427 | Ali et al. | Feb 2006 | B2 |
6998247 | Monfre et al. | Feb 2006 | B2 |
6999904 | Weber et al. | Feb 2006 | B2 |
7003338 | Weber et al. | Feb 2006 | B2 |
7003339 | Diab et al. | Feb 2006 | B2 |
7015451 | Dalke et al. | Mar 2006 | B2 |
7024233 | Ali et al. | Apr 2006 | B2 |
7027849 | Al-Ali | Apr 2006 | B2 |
7030749 | Al-Ali | Apr 2006 | B2 |
7039449 | Al-Ali | May 2006 | B2 |
7041060 | Flaherty et al. | May 2006 | B2 |
7044918 | Diab | May 2006 | B2 |
7048687 | Reuss et al. | May 2006 | B1 |
7067893 | Mills et al. | Jun 2006 | B2 |
D526719 | Richie, Jr. et al. | Aug 2006 | S |
7096052 | Mason et al. | Aug 2006 | B2 |
7096054 | Abdul-Hafiz et al. | Aug 2006 | B2 |
D529616 | Deros et al. | Oct 2006 | S |
7132641 | Schulz et al. | Nov 2006 | B2 |
7133710 | Acosta et al. | Nov 2006 | B2 |
7142901 | Kiani et al. | Nov 2006 | B2 |
7149561 | Diab | Dec 2006 | B2 |
7186966 | Al-Ali | Mar 2007 | B2 |
7190261 | Al-Ali | Mar 2007 | B2 |
7215984 | Diab et al. | May 2007 | B2 |
7215986 | Diab et al. | May 2007 | B2 |
7221971 | Diab et al. | May 2007 | B2 |
7225006 | Al-Ali et al. | May 2007 | B2 |
7225007 | Al-Ali et al. | May 2007 | B2 |
RE39672 | Shehada et al. | Jun 2007 | E |
7239905 | Kiani-Azarbayjany et al. | Jul 2007 | B2 |
7245953 | Parker | Jul 2007 | B1 |
7254429 | Schurman et al. | Aug 2007 | B2 |
7254431 | Al-Ali et al. | Aug 2007 | B2 |
7254433 | Diab et al. | Aug 2007 | B2 |
7254434 | Schulz et al. | Aug 2007 | B2 |
7272425 | Al-Ali | Sep 2007 | B2 |
7274955 | Kiani et al. | Sep 2007 | B2 |
D554263 | Al-Ali et al. | Oct 2007 | S |
7280858 | Al-Ali et al. | Oct 2007 | B2 |
7289835 | Mansfield et al. | Oct 2007 | B2 |
7292883 | De Felice et al. | Nov 2007 | B2 |
7295866 | Al-Ali | Nov 2007 | B2 |
7328053 | Diab et al. | Feb 2008 | B1 |
7332784 | Mills et al. | Feb 2008 | B2 |
7340287 | Mason et al. | Mar 2008 | B2 |
7341559 | Schulz et al. | Mar 2008 | B2 |
7343186 | Lamego et al. | Mar 2008 | B2 |
D566282 | Al-Ali et al. | Apr 2008 | S |
7355512 | Al-Ali | Apr 2008 | B1 |
7356365 | Schurman | Apr 2008 | B2 |
7371981 | Abdul-Hafiz | May 2008 | B2 |
7373193 | Al-Ali et al. | May 2008 | B2 |
7373194 | Weber et al. | May 2008 | B2 |
7376453 | Diab et al. | May 2008 | B1 |
7377794 | Al-Ali et al. | May 2008 | B2 |
7377899 | Weber et al. | May 2008 | B2 |
7383070 | Diab et al. | Jun 2008 | B2 |
7395158 | Monfre et al. | Jul 2008 | B2 |
7415297 | Al-Ali et al. | Aug 2008 | B2 |
7428432 | Ali et al. | Sep 2008 | B2 |
7438683 | Al-Ali et al. | Oct 2008 | B2 |
7440787 | Diab | Oct 2008 | B2 |
7454240 | Diab et al. | Nov 2008 | B2 |
7467002 | Weber et al. | Dec 2008 | B2 |
7469157 | Diab et al. | Dec 2008 | B2 |
7471969 | Diab et al. | Dec 2008 | B2 |
7471971 | Diab et al. | Dec 2008 | B2 |
7483729 | Al-Ali et al. | Jan 2009 | B2 |
7483730 | Diab et al. | Jan 2009 | B2 |
7489958 | Diab et al. | Feb 2009 | B2 |
7496391 | Diab et al. | Feb 2009 | B2 |
7496393 | Diab et al. | Feb 2009 | B2 |
D587657 | Al-Ali et al. | Mar 2009 | S |
7499741 | Diab et al. | Mar 2009 | B2 |
7499835 | Weber et al. | Mar 2009 | B2 |
7500950 | Al-Ali et al. | Mar 2009 | B2 |
7509154 | Diab et al. | Mar 2009 | B2 |
7509494 | Al-Ali | Mar 2009 | B2 |
7510849 | Schurman et al. | Mar 2009 | B2 |
7514725 | Wojtczuk et al. | Apr 2009 | B2 |
7519406 | Blank et al. | Apr 2009 | B2 |
7526328 | Diab et al. | Apr 2009 | B2 |
D592507 | Wachman et al. | May 2009 | S |
7530942 | Diab | May 2009 | B1 |
7530949 | Al Ali et al. | May 2009 | B2 |
7530955 | Diab et al. | May 2009 | B2 |
7563110 | Al-Ali et al. | Jul 2009 | B2 |
7593230 | Abul-Haj et al. | Sep 2009 | B2 |
7596398 | Al-Ali et al. | Sep 2009 | B2 |
7606608 | Blank et al. | Oct 2009 | B2 |
7618375 | Flaherty et al. | Nov 2009 | B2 |
7620674 | Ruchti et al. | Nov 2009 | B2 |
D606659 | Kiani et al. | Dec 2009 | S |
7629039 | Eckerbom et al. | Dec 2009 | B2 |
7640140 | Ruchti et al. | Dec 2009 | B2 |
7647083 | Al-Ali et al. | Jan 2010 | B2 |
D609193 | Al-Ali et al. | Feb 2010 | S |
D614305 | Al-Ali et al. | Apr 2010 | S |
7697966 | Monfre et al. | Apr 2010 | B2 |
7698105 | Ruchti et al. | Apr 2010 | B2 |
RE41317 | Parker | May 2010 | E |
RE41333 | Blank et al. | May 2010 | E |
7729733 | Al-Ali et al. | Jun 2010 | B2 |
7734320 | Al-Ali | Jun 2010 | B2 |
7761127 | Al-Ali et al. | Jul 2010 | B2 |
7761128 | Al-Ali et al. | Jul 2010 | B2 |
7764982 | Dalke et al. | Jul 2010 | B2 |
D621516 | Kiani et al. | Aug 2010 | S |
7791155 | Diab | Sep 2010 | B2 |
7801581 | Diab | Sep 2010 | B2 |
7822452 | Schurman et al. | Oct 2010 | B2 |
RE41912 | Parker | Nov 2010 | E |
7844313 | Kiani et al. | Nov 2010 | B2 |
7844314 | Al-Ali | Nov 2010 | B2 |
7844315 | Al-Ali | Nov 2010 | B2 |
7865222 | Weber et al. | Jan 2011 | B2 |
7873497 | Weber et al. | Jan 2011 | B2 |
7880606 | Al-Ali | Feb 2011 | B2 |
7880626 | Al-Ali et al. | Feb 2011 | B2 |
7891355 | Al-Ali et al. | Feb 2011 | B2 |
7894868 | Al-Ali et al. | Feb 2011 | B2 |
7899507 | Al-Ali et al. | Mar 2011 | B2 |
7899518 | Trepagnier et al. | Mar 2011 | B2 |
7904132 | Weber et al. | Mar 2011 | B2 |
7909772 | Popov et al. | Mar 2011 | B2 |
7910875 | Ai-Ali | Mar 2011 | B2 |
7919713 | Al-Ali et al. | Apr 2011 | B2 |
7937128 | Al-Ali | May 2011 | B2 |
7937129 | Mason et al. | May 2011 | B2 |
7937130 | Diab et al. | May 2011 | B2 |
7941199 | Kiani | May 2011 | B2 |
7951086 | Flaherty et al. | May 2011 | B2 |
7957780 | Lamego et al. | Jun 2011 | B2 |
7962188 | Kiani et al. | Jun 2011 | B2 |
7962190 | Diab et al. | Jun 2011 | B1 |
7976472 | Kiani | Jul 2011 | B2 |
7988637 | Diab | Aug 2011 | B2 |
7990382 | Kiani | Aug 2011 | B2 |
7991446 | Ali et al. | Aug 2011 | B2 |
8000761 | Al-Ali | Aug 2011 | B2 |
8008088 | Bellott et al. | Aug 2011 | B2 |
RE42753 | Kiani-Azarbayjany et al. | Sep 2011 | E |
8019400 | Diab et al. | Sep 2011 | B2 |
8028701 | Al-Ali et al. | Oct 2011 | B2 |
8029765 | Bellott et al. | Oct 2011 | B2 |
8036727 | Schurman et al. | Oct 2011 | B2 |
8036728 | Diab et al. | Oct 2011 | B2 |
8046040 | Ali et al. | Oct 2011 | B2 |
8046041 | Diab et al. | Oct 2011 | B2 |
8046042 | Diab et al. | Oct 2011 | B2 |
8048040 | Kiani | Nov 2011 | B2 |
8050728 | Al-Ali et al. | Nov 2011 | B2 |
RE43169 | Parker | Feb 2012 | E |
8118620 | Al-Ali et al. | Feb 2012 | B2 |
8126528 | Diab et al. | Feb 2012 | B2 |
8128572 | Diab et al. | Mar 2012 | B2 |
8130105 | Al-Ali et al. | Mar 2012 | B2 |
8145287 | Diab et al. | Mar 2012 | B2 |
8150487 | Diab et al. | Apr 2012 | B2 |
8175672 | Parker | May 2012 | B2 |
8180420 | Diab et al. | May 2012 | B2 |
8182443 | Kiani | May 2012 | B1 |
8185180 | Diab et al. | May 2012 | B2 |
8190223 | Al-Ali et al. | May 2012 | B2 |
8190227 | Diab et al. | May 2012 | B2 |
8203438 | Kiani et al. | Jun 2012 | B2 |
8203704 | Merritt et al. | Jun 2012 | B2 |
8204566 | Schurman et al. | Jun 2012 | B2 |
8219172 | Schurman et al. | Jul 2012 | B2 |
8224411 | Al-Ali et al. | Jul 2012 | B2 |
8228181 | Al-Ali | Jul 2012 | B2 |
8229532 | Davis | Jul 2012 | B2 |
8229533 | Diab et al. | Jul 2012 | B2 |
8233955 | Al-Ali et al. | Jul 2012 | B2 |
8244325 | Al-Ali et al. | Aug 2012 | B2 |
8255026 | Al-Ali | Aug 2012 | B1 |
8255027 | Al-Ali et al. | Aug 2012 | B2 |
8255028 | Al-Ali et al. | Aug 2012 | B2 |
8260577 | Weber et al. | Sep 2012 | B2 |
8265723 | McHale et al. | Sep 2012 | B1 |
8274360 | Sampath et al. | Sep 2012 | B2 |
8280473 | Al-Ali | Oct 2012 | B2 |
8301216 | Durkin | Oct 2012 | B2 |
8301217 | Al-Ali et al. | Oct 2012 | B2 |
8306596 | Schurman et al. | Nov 2012 | B2 |
8310336 | Muhsin et al. | Nov 2012 | B2 |
8315683 | Al-Ali et al. | Nov 2012 | B2 |
RE43860 | Parker | Dec 2012 | E |
8337403 | Al-Ali et al. | Dec 2012 | B2 |
8346330 | Lamego | Jan 2013 | B2 |
8353842 | Al-Ali et al. | Jan 2013 | B2 |
8355766 | MacNeish, III et al. | Jan 2013 | B2 |
8359080 | Diab et al. | Jan 2013 | B2 |
8364223 | Al-Ali et al. | Jan 2013 | B2 |
8364226 | Diab et al. | Jan 2013 | B2 |
8374665 | Lamego | Feb 2013 | B2 |
8385995 | Al-Ali et al. | Feb 2013 | B2 |
8385996 | Smith et al. | Feb 2013 | B2 |
8388353 | Kiani et al. | Mar 2013 | B2 |
8399822 | Al-Ali | Mar 2013 | B2 |
8401602 | Kiani | Mar 2013 | B2 |
8405608 | Al-Ali et al. | Mar 2013 | B2 |
8414499 | Al-Ali et al. | Apr 2013 | B2 |
8418524 | Al-Ali | Apr 2013 | B2 |
8423106 | Lamego et al. | Apr 2013 | B2 |
8428967 | Olsen et al. | Apr 2013 | B2 |
8430817 | Al-Ali et al. | Apr 2013 | B1 |
8437825 | Dalvi et al. | May 2013 | B2 |
8455290 | Siskavich | Jun 2013 | B2 |
8457703 | Al-Ali | Jun 2013 | B2 |
8457707 | Kiani | Jun 2013 | B2 |
8463349 | Diab et al. | Jun 2013 | B2 |
8466286 | Bellott et al. | Jun 2013 | B2 |
8471713 | Poeze et al. | Jun 2013 | B2 |
8473020 | Kiani et al. | Jun 2013 | B2 |
8483787 | Al-Ali et al. | Jul 2013 | B2 |
8489364 | Weber et al. | Jul 2013 | B2 |
8498684 | Weber et al. | Jul 2013 | B2 |
8504128 | Blank et al. | Aug 2013 | B2 |
8509867 | Workman et al. | Aug 2013 | B2 |
8515509 | Bruinsma et al. | Aug 2013 | B2 |
8523781 | Al-Ali | Sep 2013 | B2 |
8529301 | Al-Ali et al. | Sep 2013 | B2 |
8532727 | Ali et al. | Sep 2013 | B2 |
8532728 | Diab et al. | Sep 2013 | B2 |
D692145 | Al-Ali et al. | Oct 2013 | S |
8547209 | Kiani et al. | Oct 2013 | B2 |
8548548 | Al-Ali | Oct 2013 | B2 |
8548549 | Schurman et al. | Oct 2013 | B2 |
8548550 | Al-Ali et al. | Oct 2013 | B2 |
8560032 | Al-Ali et al. | Oct 2013 | B2 |
8560034 | Diab et al. | Oct 2013 | B1 |
8570167 | Al-Ali | Oct 2013 | B2 |
8570503 | Vo et al. | Oct 2013 | B2 |
8571617 | Reichgott et al. | Oct 2013 | B2 |
8571618 | Lamego et al. | Oct 2013 | B1 |
8571619 | Al-Ali et al. | Oct 2013 | B2 |
8577431 | Lamego et al. | Nov 2013 | B2 |
8581732 | Al-Ali et al. | Nov 2013 | B2 |
8584345 | Al-Ali et al. | Nov 2013 | B2 |
8588880 | Abdul-Hafiz et al. | Nov 2013 | B2 |
8600467 | Al-Ali et al. | Dec 2013 | B2 |
8606342 | Diab | Dec 2013 | B2 |
8626255 | Al-Ali et al. | Jan 2014 | B2 |
8630691 | Lamego et al. | Jan 2014 | B2 |
8634889 | Al-Ali et al. | Jan 2014 | B2 |
8641631 | Sierra et al. | Feb 2014 | B2 |
8652060 | Al-Ali | Feb 2014 | B2 |
8663107 | Kiani | Mar 2014 | B2 |
8666468 | Al-Ali | Mar 2014 | B1 |
8667967 | Al-Ali et al. | Mar 2014 | B2 |
8670811 | O'Reilly | Mar 2014 | B2 |
8670814 | Diab et al. | Mar 2014 | B2 |
8676286 | Weber et al. | Mar 2014 | B2 |
8682407 | Al-Ali | Mar 2014 | B2 |
RE44823 | Parker | Apr 2014 | E |
RE44875 | Kiani et al. | Apr 2014 | E |
8688183 | Bruinsma et al. | Apr 2014 | B2 |
8690799 | Telfort et al. | Apr 2014 | B2 |
8700112 | Kiani | Apr 2014 | B2 |
8702627 | Telfort et al. | Apr 2014 | B2 |
8706179 | Parker | Apr 2014 | B2 |
8712494 | MacNeish, III et al. | Apr 2014 | B1 |
8715206 | Telfort et al. | May 2014 | B2 |
8718735 | Lamego et al. | May 2014 | B2 |
8718737 | Diab et al. | May 2014 | B2 |
8718738 | Blank et al. | May 2014 | B2 |
8720249 | Al-Ali | May 2014 | B2 |
8721541 | Al-Ali et al. | May 2014 | B2 |
8721542 | Al-Ali et al. | May 2014 | B2 |
8723677 | Kiani | May 2014 | B1 |
8740792 | Kiani et al. | Jun 2014 | B1 |
8754776 | Poeze et al. | Jun 2014 | B2 |
8755535 | Telfort et al. | Jun 2014 | B2 |
8755856 | Diab et al. | Jun 2014 | B2 |
8755872 | Marinow | Jun 2014 | B1 |
8761850 | Lamego | Jun 2014 | B2 |
8764671 | Kiani | Jul 2014 | B2 |
8768423 | Shakespeare et al. | Jul 2014 | B2 |
8771204 | Telfort et al. | Jul 2014 | B2 |
8777634 | Kiani et al. | Jul 2014 | B2 |
8781543 | Diab et al. | Jul 2014 | B2 |
8781544 | Al-Ali et al. | Jul 2014 | B2 |
8781549 | Al-Ali et al. | Jul 2014 | B2 |
8788003 | Schurman et al. | Jul 2014 | B2 |
8790268 | Al-Ali | Jul 2014 | B2 |
8801613 | Al-Ali et al. | Aug 2014 | B2 |
8821397 | Al-Ali et al. | Sep 2014 | B2 |
8821415 | Al-Ali et al. | Sep 2014 | B2 |
8830449 | Lamego et al. | Sep 2014 | B1 |
8831700 | Schurman et al. | Sep 2014 | B2 |
8840549 | Al-Ali et al. | Sep 2014 | B2 |
8847740 | Kiani et al. | Sep 2014 | B2 |
8849365 | Smith et al. | Sep 2014 | B2 |
8852094 | Al-Ali et al. | Oct 2014 | B2 |
8852994 | Wojtczuk et al. | Oct 2014 | B2 |
8868147 | Stippick et al. | Oct 2014 | B2 |
8868150 | Al-Ali et al. | Oct 2014 | B2 |
8870792 | Al-Ali et al. | Oct 2014 | B2 |
8886271 | Kiani et al. | Nov 2014 | B2 |
8888539 | Al-Ali et al. | Nov 2014 | B2 |
8888701 | LeBoeuf | Nov 2014 | B2 |
8888708 | Diab et al. | Nov 2014 | B2 |
8892180 | Weber et al. | Nov 2014 | B2 |
8897847 | Al-Ali | Nov 2014 | B2 |
8909310 | Lamego et al. | Dec 2014 | B2 |
8911377 | Al-Ali | Dec 2014 | B2 |
8912909 | Al-Ali et al. | Dec 2014 | B2 |
8920317 | Al-Ali et al. | Dec 2014 | B2 |
8921699 | Al-Ali et al. | Dec 2014 | B2 |
8922382 | Al-Ali et al. | Dec 2014 | B2 |
8929964 | Al-Ali et al. | Jan 2015 | B2 |
8942777 | Diab et al. | Jan 2015 | B2 |
8948834 | Diab et al. | Feb 2015 | B2 |
8948835 | Diab | Feb 2015 | B2 |
8965471 | Lamego | Feb 2015 | B2 |
8983564 | Al-Ali | Mar 2015 | B2 |
8989831 | Al-Ali et al. | Mar 2015 | B2 |
8996085 | Kiani et al. | Mar 2015 | B2 |
8998809 | Kiani | Apr 2015 | B2 |
9028429 | Telfort et al. | May 2015 | B2 |
9037207 | Al-Ali et al. | May 2015 | B2 |
9060721 | Reichgott et al. | Jun 2015 | B2 |
9066666 | Kiani | Jun 2015 | B2 |
9066680 | Al-Ali et al. | Jun 2015 | B1 |
9072474 | Al-Ali et al. | Jul 2015 | B2 |
9078560 | Schurman et al. | Jul 2015 | B2 |
9084569 | Weber et al. | Jul 2015 | B2 |
9095316 | Welch et al. | Aug 2015 | B2 |
9106038 | Telfort et al. | Aug 2015 | B2 |
9107625 | Telfort et al. | Aug 2015 | B2 |
9107626 | Al-Ali et al. | Aug 2015 | B2 |
9113831 | Al-Ali | Aug 2015 | B2 |
9113832 | Al-Ali | Aug 2015 | B2 |
9119595 | Lamego | Sep 2015 | B2 |
9131881 | Diab et al. | Sep 2015 | B2 |
9131882 | Al-Ali et al. | Sep 2015 | B2 |
9131883 | Al-Ali | Sep 2015 | B2 |
9131917 | Telfort et al. | Sep 2015 | B2 |
9138180 | Coverston et al. | Sep 2015 | B1 |
9138182 | Al-Ali et al. | Sep 2015 | B2 |
9138192 | Weber et al. | Sep 2015 | B2 |
9142117 | Muhsin et al. | Sep 2015 | B2 |
9153112 | Kiani et al. | Oct 2015 | B1 |
9153121 | Kiani et al. | Oct 2015 | B2 |
9161696 | Al-Ali et al. | Oct 2015 | B2 |
9161713 | Al-Ali et al. | Oct 2015 | B2 |
9167995 | Lamego et al. | Oct 2015 | B2 |
9176141 | Al-Ali et al. | Nov 2015 | B2 |
9186102 | Bruinsma et al. | Nov 2015 | B2 |
9192312 | Al-Ali | Nov 2015 | B2 |
9192329 | Al-Ali | Nov 2015 | B2 |
9192351 | Telfort et al. | Nov 2015 | B1 |
9195385 | Al-Ali et al. | Nov 2015 | B2 |
9211072 | Kiani | Dec 2015 | B2 |
9211095 | Al-Ali | Dec 2015 | B1 |
9218454 | Kiani et al. | Dec 2015 | B2 |
9226696 | Kiani | Jan 2016 | B2 |
9241662 | Al-Ali et al. | Jan 2016 | B2 |
9245668 | Vo et al. | Jan 2016 | B1 |
9259185 | Abdul-Hafiz et al. | Feb 2016 | B2 |
9267572 | Barker et al. | Feb 2016 | B2 |
9277880 | Poeze et al. | Mar 2016 | B2 |
9289167 | Diab et al. | Mar 2016 | B2 |
9295421 | Kiani et al. | Mar 2016 | B2 |
9307928 | Al-Ali et al. | Apr 2016 | B1 |
9323894 | Kiani | Apr 2016 | B2 |
D755392 | Hwang et al. | May 2016 | S |
9326712 | Kiani | May 2016 | B1 |
9333316 | Kiani | May 2016 | B2 |
9339220 | Lamego et al. | May 2016 | B2 |
9341565 | Lamego et al. | May 2016 | B2 |
9351673 | Diab et al. | May 2016 | B2 |
9351675 | Al-Ali et al. | May 2016 | B2 |
9364181 | Kiani et al. | Jun 2016 | B2 |
9368671 | Wojtczuk et al. | Jun 2016 | B2 |
9370325 | Al-Ali et al. | Jun 2016 | B2 |
9370326 | McHale et al. | Jun 2016 | B2 |
9370335 | Al-Ali et al. | Jun 2016 | B2 |
9375185 | Ali et al. | Jun 2016 | B2 |
9386953 | Al-Ali | Jul 2016 | B2 |
9386961 | Al-Ali et al. | Jul 2016 | B2 |
9392945 | Al-Ali et al. | Jul 2016 | B2 |
9397448 | Al-Ali et al. | Jul 2016 | B2 |
9408542 | Kinast et al. | Aug 2016 | B1 |
9436645 | Al-Ali et al. | Sep 2016 | B2 |
9445759 | Lamego et al. | Sep 2016 | B1 |
9466919 | Kiani et al. | Oct 2016 | B2 |
9474474 | Lamego et al. | Oct 2016 | B2 |
9480422 | Al-Ali | Nov 2016 | B2 |
9480435 | Olsen | Nov 2016 | B2 |
9492110 | Al-Ali et al. | Nov 2016 | B2 |
9510779 | Poeze et al. | Dec 2016 | B2 |
9517024 | Kiani et al. | Dec 2016 | B2 |
9532722 | Lamego et al. | Jan 2017 | B2 |
9538949 | Al-Ali et al. | Jan 2017 | B2 |
9538980 | Telfort et al. | Jan 2017 | B2 |
9549696 | Lamego et al. | Jan 2017 | B2 |
9554737 | Schurman et al. | Jan 2017 | B2 |
9560996 | Kiani | Feb 2017 | B2 |
9560998 | Al-Ali et al. | Feb 2017 | B2 |
9566019 | Al-Ali et al. | Feb 2017 | B2 |
9579039 | Jansen et al. | Feb 2017 | B2 |
9591975 | Dalvi et al. | Mar 2017 | B2 |
9622692 | Lamego et al. | Apr 2017 | B2 |
9622693 | Diab | Apr 2017 | B2 |
D788312 | Al-Ali et al. | May 2017 | S |
9636055 | Al Ali et al. | May 2017 | B2 |
9636056 | Al-Ali | May 2017 | B2 |
9649054 | Lamego et al. | May 2017 | B2 |
9662052 | Al-Ali et al. | May 2017 | B2 |
9668679 | Schurman et al. | Jun 2017 | B2 |
9668680 | Bruinsma et al. | Jun 2017 | B2 |
9668703 | Al-Ali | Jun 2017 | B2 |
9675286 | Diab | Jun 2017 | B2 |
9687160 | Kiani | Jun 2017 | B2 |
9693719 | Al-Ali et al. | Jul 2017 | B2 |
9693737 | Al-Ali | Jul 2017 | B2 |
9697928 | Al-Ali et al. | Jul 2017 | B2 |
9717425 | Kiani et al. | Aug 2017 | B2 |
9717458 | Lamego et al. | Aug 2017 | B2 |
9724016 | Al-Ali et al. | Aug 2017 | B1 |
9724024 | Al-Ali | Aug 2017 | B2 |
9724025 | Kiani et al. | Aug 2017 | B1 |
9730640 | Diab et al. | Aug 2017 | B2 |
9743887 | Al-Ali et al. | Aug 2017 | B2 |
9748307 | Cheng | Aug 2017 | B2 |
9749232 | Sampath et al. | Aug 2017 | B2 |
9750442 | Olsen | Sep 2017 | B2 |
9750443 | Smith et al. | Sep 2017 | B2 |
9750461 | Telfort | Sep 2017 | B1 |
9775545 | Al-Ali et al. | Oct 2017 | B2 |
9775546 | Diab et al. | Oct 2017 | B2 |
9775570 | Al-Ali | Oct 2017 | B2 |
9778079 | Al-Ali et al. | Oct 2017 | B1 |
9782077 | Lamego et al. | Oct 2017 | B2 |
9782110 | Kiani | Oct 2017 | B2 |
9787568 | Lamego et al. | Oct 2017 | B2 |
9788735 | Al-Ali | Oct 2017 | B2 |
9788768 | Al-Ali et al. | Oct 2017 | B2 |
9795300 | Al-Ali | Oct 2017 | B2 |
9795310 | Al-Ali | Oct 2017 | B2 |
9795358 | Telfort et al. | Oct 2017 | B2 |
9795739 | Al-Ali et al. | Oct 2017 | B2 |
9801556 | Kiani | Oct 2017 | B2 |
9801588 | Weber et al. | Oct 2017 | B2 |
9808188 | Perea et al. | Nov 2017 | B1 |
9814418 | Weber et al. | Nov 2017 | B2 |
9820691 | Kiani | Nov 2017 | B2 |
9833152 | Kiani et al. | Dec 2017 | B2 |
9833180 | Shakespeare et al. | Dec 2017 | B2 |
9839379 | Al-Ali et al. | Dec 2017 | B2 |
9839381 | Weber et al. | Dec 2017 | B1 |
9847002 | Kiani et al. | Dec 2017 | B2 |
9847749 | Kiani et al. | Dec 2017 | B2 |
9848800 | Lee et al. | Dec 2017 | B1 |
9848806 | Al-Ali | Dec 2017 | B2 |
9848807 | Lamego | Dec 2017 | B2 |
9861298 | Eckerbom et al. | Jan 2018 | B2 |
9861304 | Al-Ali et al. | Jan 2018 | B2 |
9861305 | Weber et al. | Jan 2018 | B1 |
9867578 | Al-Ali et al. | Jan 2018 | B2 |
9872623 | Al-Ali | Jan 2018 | B2 |
9876320 | Coverston et al. | Jan 2018 | B2 |
9877650 | Muhsin et al. | Jan 2018 | B2 |
9877686 | Al-Ali et al. | Jan 2018 | B2 |
9891079 | Dalvi | Feb 2018 | B2 |
9895107 | Al-Ali et al. | Feb 2018 | B2 |
9924893 | Schurman et al. | Mar 2018 | B2 |
9924897 | Abdul-Hafiz | Mar 2018 | B1 |
9936917 | Poeze et al. | Apr 2018 | B2 |
9955937 | Telfort | May 2018 | B2 |
9965946 | Al-Ali et al. | May 2018 | B2 |
D820865 | Muhsin et al. | Jun 2018 | S |
9986952 | Dalvi et al. | Jun 2018 | B2 |
D822215 | Al-Ali et al. | Jul 2018 | S |
D822216 | Barker et al. | Jul 2018 | S |
10010276 | Al-Ali et al. | Jul 2018 | B2 |
10086138 | Novak, Jr. | Oct 2018 | B1 |
10111591 | Dyell et al. | Oct 2018 | B2 |
D833624 | DeJong et al. | Nov 2018 | S |
10123729 | Dyell et al. | Nov 2018 | B2 |
D835282 | Barker et al. | Dec 2018 | S |
D835283 | Barker et al. | Dec 2018 | S |
D835284 | Barker et al. | Dec 2018 | S |
D835285 | Barker et al. | Dec 2018 | S |
10149616 | Al-Ali et al. | Dec 2018 | B2 |
10154815 | Al-Ali et al. | Dec 2018 | B2 |
10159412 | Lamego et al. | Dec 2018 | B2 |
10188348 | Al-Ali et al. | Jan 2019 | B2 |
RE47218 | Al-Ali | Feb 2019 | E |
RE47244 | Kiani et al. | Feb 2019 | E |
RE47249 | Kiani et al. | Feb 2019 | E |
10205291 | Scruggs et al. | Feb 2019 | B2 |
10226187 | Al-Ali et al. | Mar 2019 | B2 |
10231657 | Al-Ali et al. | Mar 2019 | B2 |
10231670 | Blank et al. | Mar 2019 | B2 |
RE47353 | Kiani et al. | Apr 2019 | E |
10279247 | Kiani | May 2019 | B2 |
10292664 | Al-Ali | May 2019 | B2 |
10299720 | Brown et al. | May 2019 | B2 |
10327337 | Schmidt et al. | Jun 2019 | B2 |
10327713 | Barker et al. | Jun 2019 | B2 |
10332630 | Al-Ali | Jun 2019 | B2 |
10383520 | Wojtczuk et al. | Aug 2019 | B2 |
10383527 | Al-Ali | Aug 2019 | B2 |
10388120 | Muhsin et al. | Aug 2019 | B2 |
D864120 | Forrest et al. | Oct 2019 | S |
10441181 | Telfort et al. | Oct 2019 | B1 |
10441196 | Eckerbom et al. | Oct 2019 | B2 |
10448844 | Al-Ali et al. | Oct 2019 | B2 |
10448871 | Al-Ali et al. | Oct 2019 | B2 |
10456038 | Lamego et al. | Oct 2019 | B2 |
10463340 | Telfort et al. | Nov 2019 | B2 |
10471159 | Lapotko et al. | Nov 2019 | B1 |
10505311 | Al-Ali et al. | Dec 2019 | B2 |
10524738 | Olsen | Jan 2020 | B2 |
10532174 | Al-Ali | Jan 2020 | B2 |
10537285 | Shreim et al. | Jan 2020 | B2 |
10542903 | Al-Ali et al. | Jan 2020 | B2 |
10555678 | Dalvi et al. | Feb 2020 | B2 |
10568514 | Wojtczuk et al. | Feb 2020 | B2 |
10568553 | O'Neil et al. | Feb 2020 | B2 |
RE47882 | Al-Ali | Mar 2020 | E |
10608817 | Haider et al. | Mar 2020 | B2 |
D880477 | Forrest et al. | Apr 2020 | S |
10617302 | Al-Ali et al. | Apr 2020 | B2 |
10617335 | Al-Ali et al. | Apr 2020 | B2 |
10637181 | Al-Ali et al. | Apr 2020 | B2 |
D886849 | Muhsin et al. | Jun 2020 | S |
D887548 | Abdul-Hafiz et al. | Jun 2020 | S |
D887549 | Abdul-Hafiz et al. | Jun 2020 | S |
10667764 | Ahmed et al. | Jun 2020 | B2 |
D890708 | Forrest et al. | Jul 2020 | S |
10721785 | Al-Ali | Jul 2020 | B2 |
10736518 | Al-Ali et al. | Aug 2020 | B2 |
10750984 | Pauley et al. | Aug 2020 | B2 |
D897098 | Al-Ali | Sep 2020 | S |
10779098 | Iswanto et al. | Sep 2020 | B2 |
10827961 | Iyengar et al. | Nov 2020 | B1 |
10827979 | LeBoeuf | Nov 2020 | B2 |
10828007 | Telfort et al. | Nov 2020 | B1 |
10832818 | Muhsin et al. | Nov 2020 | B2 |
10849554 | Shreim et al. | Dec 2020 | B2 |
10856750 | Indorf | Dec 2020 | B2 |
D906970 | Forrest et al. | Jan 2021 | S |
D908213 | Abdul-Hafiz et al. | Jan 2021 | S |
10918281 | Al-Ali et al. | Feb 2021 | B2 |
10932705 | Muhsin et al. | Mar 2021 | B2 |
10932729 | Kiani et al. | Mar 2021 | B2 |
10939878 | Kiani et al. | Mar 2021 | B2 |
10956950 | Al-Ali et al. | Mar 2021 | B2 |
D916135 | Indorf et al. | Apr 2021 | S |
D917046 | Abdul-Hafiz et al. | Apr 2021 | S |
D917550 | Indorf et al. | Apr 2021 | S |
D917564 | Indorf et al. | Apr 2021 | S |
D917704 | Al-Ali et al. | Apr 2021 | S |
10987066 | Chandran et al. | Apr 2021 | B2 |
10991135 | Al-Ali et al. | Apr 2021 | B2 |
D919094 | Al-Ali et al. | May 2021 | S |
D919100 | Al-Ali et al. | May 2021 | S |
11006867 | Al-Ali | May 2021 | B2 |
D921202 | Al-Ali et al. | Jun 2021 | S |
11024064 | Muhsin et al. | Jun 2021 | B2 |
11026604 | Chen et al. | Jun 2021 | B2 |
D925597 | Chandran et al. | Jul 2021 | S |
D927699 | Al-Ali et al. | Aug 2021 | S |
11076777 | Lee et al. | Aug 2021 | B2 |
11103134 | Wojtczuk et al. | Aug 2021 | B2 |
11114188 | Poeze et al. | Sep 2021 | B2 |
D933232 | Al-Ali et al. | Oct 2021 | S |
D933233 | Al-Ali et al. | Oct 2021 | S |
D933234 | Al-Ali et al. | Oct 2021 | S |
11145408 | Sampath et al. | Oct 2021 | B2 |
11147518 | Al-Ali et al. | Oct 2021 | B1 |
11185262 | Al-Ali et al. | Nov 2021 | B2 |
11191484 | Kiani et al. | Dec 2021 | B2 |
D946596 | Ahmed | Mar 2022 | S |
D946597 | Ahmed | Mar 2022 | S |
D946598 | Ahmed | Mar 2022 | S |
D946617 | Ahmed | Mar 2022 | S |
11272839 | Al-Ali et al. | Mar 2022 | B2 |
11289199 | Al-Ali | Mar 2022 | B2 |
RE49034 | Al-Ali | Apr 2022 | E |
11298021 | Muhsin et al. | Apr 2022 | B2 |
D950580 | Ahmed | May 2022 | S |
D950599 | Ahmed | May 2022 | S |
D950738 | Al-Ali et al. | May 2022 | S |
11324445 | LeBoeuf | May 2022 | B2 |
D957648 | Al-Ali | Jul 2022 | S |
11389093 | Triman et al. | Jul 2022 | B2 |
11406286 | Al-Ali et al. | Aug 2022 | B2 |
11417426 | Muhsin et al. | Aug 2022 | B2 |
11439329 | Lamego | Sep 2022 | B2 |
11445948 | Scruggs et al. | Sep 2022 | B2 |
D965789 | Al-Ali et al. | Oct 2022 | S |
D967433 | Al-Ali et al. | Oct 2022 | S |
11464410 | Muhsin | Oct 2022 | B2 |
11504058 | Sharma et al. | Nov 2022 | B1 |
11504066 | Dalvi et al. | Nov 2022 | B1 |
D971933 | Ahmed | Dec 2022 | S |
D973072 | Ahmed | Dec 2022 | S |
D973685 | Ahmed | Dec 2022 | S |
D973686 | Ahmed | Dec 2022 | S |
D974193 | Forrest et al. | Jan 2023 | S |
D979516 | Al-Ali et al. | Feb 2023 | S |
D980091 | Forrest et al. | Mar 2023 | S |
11596363 | Lamego | Mar 2023 | B2 |
20010034477 | Mansfield et al. | Oct 2001 | A1 |
20010039483 | Brand et al. | Nov 2001 | A1 |
20020010401 | Bushmakin et al. | Jan 2002 | A1 |
20020058864 | Mansfield et al. | May 2002 | A1 |
20020133080 | Apruzzese et al. | Sep 2002 | A1 |
20030013975 | Kiani | Jan 2003 | A1 |
20030018243 | Gerhardt et al. | Jan 2003 | A1 |
20030070707 | King | Apr 2003 | A1 |
20030144582 | Cohen et al. | Jul 2003 | A1 |
20030145884 | King | Aug 2003 | A1 |
20030156288 | Barnum et al. | Aug 2003 | A1 |
20030212312 | Coffin, IV et al. | Nov 2003 | A1 |
20040106163 | Workman, Jr. et al. | Jun 2004 | A1 |
20050055276 | Kiani et al. | Mar 2005 | A1 |
20050234317 | Kiani | Oct 2005 | A1 |
20060073719 | Kiani | Apr 2006 | A1 |
20060161054 | Reuss et al. | Jul 2006 | A1 |
20060189871 | Al-Ali et al. | Aug 2006 | A1 |
20060211922 | Al-Ali et al. | Sep 2006 | A1 |
20070073116 | Kiani et al. | Mar 2007 | A1 |
20070180140 | Welch et al. | Aug 2007 | A1 |
20070244377 | Cozad et al. | Oct 2007 | A1 |
20070282478 | Al-Ali et al. | Dec 2007 | A1 |
20080064965 | Jay et al. | Mar 2008 | A1 |
20080070340 | Borrelli | Mar 2008 | A1 |
20080094228 | Welch et al. | Apr 2008 | A1 |
20080221418 | Al-Ali et al. | Sep 2008 | A1 |
20090036759 | Ault et al. | Feb 2009 | A1 |
20090093687 | Telfort et al. | Apr 2009 | A1 |
20090095926 | MacNeish, III | Apr 2009 | A1 |
20090247984 | Lamego et al. | Oct 2009 | A1 |
20090275813 | Davis | Nov 2009 | A1 |
20090275844 | Al-Ali | Nov 2009 | A1 |
20100004518 | Vo et al. | Jan 2010 | A1 |
20100030040 | Poeze et al. | Feb 2010 | A1 |
20100099964 | O'Reilly et al. | Apr 2010 | A1 |
20100160754 | Durkin | Jun 2010 | A1 |
20100181484 | Inada | Jul 2010 | A1 |
20100210930 | Saylor | Aug 2010 | A1 |
20100218819 | Farmer | Sep 2010 | A1 |
20100234718 | Sampath et al. | Sep 2010 | A1 |
20100270257 | Wachman et al. | Oct 2010 | A1 |
20110028806 | Merritt et al. | Feb 2011 | A1 |
20110028809 | Goodman | Feb 2011 | A1 |
20110040197 | Welch et al. | Feb 2011 | A1 |
20110082711 | Poeze et al. | Apr 2011 | A1 |
20110087081 | Kiani et al. | Apr 2011 | A1 |
20110105854 | Kiani et al. | May 2011 | A1 |
20110118561 | Tari et al. | May 2011 | A1 |
20110125060 | Telfort et al. | May 2011 | A1 |
20110137297 | Kiani et al. | Jun 2011 | A1 |
20110172498 | Olsen et al. | Jul 2011 | A1 |
20110208015 | Welch et al. | Aug 2011 | A1 |
20110230733 | Al-Ali | Sep 2011 | A1 |
20110291108 | Shen | Dec 2011 | A1 |
20120123231 | O'Reilly | May 2012 | A1 |
20120165629 | Merritt et al. | Jun 2012 | A1 |
20120197093 | LeBoeuf | Aug 2012 | A1 |
20120209082 | Al-Ali | Aug 2012 | A1 |
20120209084 | Olsen et al. | Aug 2012 | A1 |
20120226117 | Lamego et al. | Sep 2012 | A1 |
20120262701 | Said | Oct 2012 | A1 |
20120283524 | Kiani et al. | Nov 2012 | A1 |
20120286328 | Nishida | Nov 2012 | A1 |
20120319816 | Al-Ali | Dec 2012 | A1 |
20130023775 | Lamego et al. | Jan 2013 | A1 |
20130041591 | Lamego | Feb 2013 | A1 |
20130060147 | Welch et al. | Mar 2013 | A1 |
20130096405 | Garfio | Apr 2013 | A1 |
20130096936 | Sampath et al. | Apr 2013 | A1 |
20130243021 | Siskavich | Sep 2013 | A1 |
20130253334 | Al-Ali et al. | Sep 2013 | A1 |
20130296672 | O'Neil et al. | Nov 2013 | A1 |
20130296713 | Al-Ali et al. | Nov 2013 | A1 |
20130324808 | Al-Ali et al. | Dec 2013 | A1 |
20130331660 | Al-Ali et al. | Dec 2013 | A1 |
20130345921 | Al-Ali et al. | Dec 2013 | A1 |
20140012100 | Al-Ali et al. | Jan 2014 | A1 |
20140051953 | Lamego et al. | Feb 2014 | A1 |
20140081175 | Telfort | Mar 2014 | A1 |
20140120564 | Workman et al. | May 2014 | A1 |
20140121482 | Merritt et al. | May 2014 | A1 |
20140127137 | Bellott et al. | May 2014 | A1 |
20140135588 | Al-Ali et al. | May 2014 | A1 |
20140163344 | Al-Ali | Jun 2014 | A1 |
20140163402 | Lamego et al. | Jun 2014 | A1 |
20140166076 | Kiani et al. | Jun 2014 | A1 |
20140171763 | Diab | Jun 2014 | A1 |
20140180038 | Kiani | Jun 2014 | A1 |
20140180154 | Sierra et al. | Jun 2014 | A1 |
20140180160 | Brown et al. | Jun 2014 | A1 |
20140187973 | Brown et al. | Jul 2014 | A1 |
20140213864 | Abdul-Hafiz et al. | Jul 2014 | A1 |
20140266790 | Al-Ali et al. | Sep 2014 | A1 |
20140275808 | Poeze et al. | Sep 2014 | A1 |
20140275835 | Lamego et al. | Sep 2014 | A1 |
20140275871 | Lamego et al. | Sep 2014 | A1 |
20140275872 | Merritt et al. | Sep 2014 | A1 |
20140276115 | Dalvi et al. | Sep 2014 | A1 |
20140288400 | Diab et al. | Sep 2014 | A1 |
20140316217 | Purdon et al. | Oct 2014 | A1 |
20140316218 | Purdon et al. | Oct 2014 | A1 |
20140316228 | Blank et al. | Oct 2014 | A1 |
20140323825 | Al-Ali et al. | Oct 2014 | A1 |
20140323897 | Brown et al. | Oct 2014 | A1 |
20140323898 | Purdon et al. | Oct 2014 | A1 |
20140330092 | Al-Ali et al. | Nov 2014 | A1 |
20140330098 | Merritt et al. | Nov 2014 | A1 |
20140357966 | Al-Ali et al. | Dec 2014 | A1 |
20150005600 | Blank et al. | Jan 2015 | A1 |
20150011907 | Purdon et al. | Jan 2015 | A1 |
20150012231 | Poeze et al. | Jan 2015 | A1 |
20150031967 | LeBoeuf | Jan 2015 | A1 |
20150032029 | Al-Ali et al. | Jan 2015 | A1 |
20150038859 | Dalvi et al. | Feb 2015 | A1 |
20150073241 | Lamego | Mar 2015 | A1 |
20150080754 | Purdon et al. | Mar 2015 | A1 |
20150087936 | Al-Ali et al. | Mar 2015 | A1 |
20150094546 | Al-Ali | Apr 2015 | A1 |
20150097701 | Muhsin et al. | Apr 2015 | A1 |
20150099950 | Al-Ali et al. | Apr 2015 | A1 |
20150099955 | Al-Ali et al. | Apr 2015 | A1 |
20150101844 | Al-Ali et al. | Apr 2015 | A1 |
20150106121 | Muhsin et al. | Apr 2015 | A1 |
20150112151 | Muhsin et al. | Apr 2015 | A1 |
20150116076 | Al-Ali et al. | Apr 2015 | A1 |
20150165312 | Kiani | Jun 2015 | A1 |
20150196249 | Brown et al. | Jul 2015 | A1 |
20150216459 | Al-Ali et al. | Aug 2015 | A1 |
20150238722 | Al-Ali | Aug 2015 | A1 |
20150245773 | Lamego et al. | Sep 2015 | A1 |
20150245794 | Al-Ali | Sep 2015 | A1 |
20150257689 | Al-Ali et al. | Sep 2015 | A1 |
20150272514 | Kiani et al. | Oct 2015 | A1 |
20150351697 | Weber et al. | Dec 2015 | A1 |
20150359429 | Al-Ali et al. | Dec 2015 | A1 |
20150366507 | Blank et al. | Dec 2015 | A1 |
20160029932 | Al-Ali | Feb 2016 | A1 |
20160058347 | Reichgott et al. | Mar 2016 | A1 |
20160066824 | Al-Ali et al. | Mar 2016 | A1 |
20160081552 | Wojtczuk et al. | Mar 2016 | A1 |
20160095543 | Telfort et al. | Apr 2016 | A1 |
20160095548 | Al-Ali et al. | Apr 2016 | A1 |
20160103598 | Al-Ali et al. | Apr 2016 | A1 |
20160143548 | Al-Ali | May 2016 | A1 |
20160166182 | Al-Ali et al. | Jun 2016 | A1 |
20160166183 | Poeze et al. | Jun 2016 | A1 |
20160192869 | Kiani et al. | Jul 2016 | A1 |
20160196388 | Lamego | Jul 2016 | A1 |
20160197436 | Barker et al. | Jul 2016 | A1 |
20160213281 | Eckerbom et al. | Jul 2016 | A1 |
20160228043 | O'Neil et al. | Aug 2016 | A1 |
20160233632 | Scruggs et al. | Aug 2016 | A1 |
20160234944 | Schmidt et al. | Aug 2016 | A1 |
20160270735 | Diab et al. | Sep 2016 | A1 |
20160283665 | Sampath et al. | Sep 2016 | A1 |
20160287090 | Al-Ali et al. | Oct 2016 | A1 |
20160287786 | Kiani | Oct 2016 | A1 |
20160296169 | McHale et al. | Oct 2016 | A1 |
20160310052 | Al-Ali et al. | Oct 2016 | A1 |
20160314260 | Kiani | Oct 2016 | A1 |
20160324486 | Al-Ali et al. | Nov 2016 | A1 |
20160324488 | Olsen | Nov 2016 | A1 |
20160327984 | Al-Ali et al. | Nov 2016 | A1 |
20160328528 | Al-Ali et al. | Nov 2016 | A1 |
20160331332 | Al-Ali | Nov 2016 | A1 |
20160367173 | Dalvi et al. | Dec 2016 | A1 |
20160374621 | LeBoeuf | Dec 2016 | A1 |
20170000394 | Al-Ali et al. | Jan 2017 | A1 |
20170007134 | Al-Ali et al. | Jan 2017 | A1 |
20170007198 | Al-Ali et al. | Jan 2017 | A1 |
20170014083 | Diab et al. | Jan 2017 | A1 |
20170014084 | Al-Ali et al. | Jan 2017 | A1 |
20170024748 | Haider | Jan 2017 | A1 |
20170027456 | Kinast et al. | Feb 2017 | A1 |
20170042488 | Muhsin | Feb 2017 | A1 |
20170055851 | Al-Ali | Mar 2017 | A1 |
20170055882 | Al-Ali et al. | Mar 2017 | A1 |
20170055887 | Al-Ali | Mar 2017 | A1 |
20170055896 | Al-Ali | Mar 2017 | A1 |
20170079594 | Telfort et al. | Mar 2017 | A1 |
20170086723 | Al-Ali et al. | Mar 2017 | A1 |
20170143281 | Olsen | May 2017 | A1 |
20170147774 | Kiani | May 2017 | A1 |
20170156620 | Al-Ali et al. | Jun 2017 | A1 |
20170173632 | Al-Ali | Jun 2017 | A1 |
20170187146 | Kiani et al. | Jun 2017 | A1 |
20170188919 | Al-Ali et al. | Jul 2017 | A1 |
20170196464 | Jansen et al. | Jul 2017 | A1 |
20170196470 | Lamego et al. | Jul 2017 | A1 |
20170202490 | Al-Ali et al. | Jul 2017 | A1 |
20170224262 | Al-Ali | Aug 2017 | A1 |
20170228516 | Sampath et al. | Aug 2017 | A1 |
20170245790 | Al-Ali et al. | Aug 2017 | A1 |
20170251974 | Shreim et al. | Sep 2017 | A1 |
20170251975 | Shreim et al. | Sep 2017 | A1 |
20170258403 | Abdul-Hafiz et al. | Sep 2017 | A1 |
20170311891 | Kiani et al. | Nov 2017 | A1 |
20170325728 | Al-Ali et al. | Nov 2017 | A1 |
20170332976 | Al-Ali | Nov 2017 | A1 |
20170340293 | Al-Ali et al. | Nov 2017 | A1 |
20170360310 | Kiani | Dec 2017 | A1 |
20170367632 | Al-Ali et al. | Dec 2017 | A1 |
20180008146 | Al-Ali et al. | Jan 2018 | A1 |
20180014752 | Al-Ali et al. | Jan 2018 | A1 |
20180028124 | Al-Ali et al. | Feb 2018 | A1 |
20180055385 | Al-Ali | Mar 2018 | A1 |
20180055390 | Kiani et al. | Mar 2018 | A1 |
20180055430 | Diab et al. | Mar 2018 | A1 |
20180055450 | LeBoeuf | Mar 2018 | A1 |
20180064381 | Shakespeare et al. | Mar 2018 | A1 |
20180069776 | Lamego et al. | Mar 2018 | A1 |
20180103874 | Lee et al. | Apr 2018 | A1 |
20180116575 | Perea et al. | May 2018 | A1 |
20180125368 | Lamego et al. | May 2018 | A1 |
20180125430 | Al-Ali et al. | May 2018 | A1 |
20180130325 | Kiani et al. | May 2018 | A1 |
20180132769 | Weber et al. | May 2018 | A1 |
20180132770 | Lamego | May 2018 | A1 |
20180242926 | Muhsin et al. | Aug 2018 | A1 |
20180247353 | Al-Ali et al. | Aug 2018 | A1 |
20180247712 | Muhsin et al. | Aug 2018 | A1 |
20180256087 | Al-Ali et al. | Sep 2018 | A1 |
20180300919 | Muhsin et al. | Oct 2018 | A1 |
20180310822 | Indorf et al. | Nov 2018 | A1 |
20180310823 | Al-Ali et al. | Nov 2018 | A1 |
20190015023 | Monfre | Jan 2019 | A1 |
20190053764 | LeBoeuf | Feb 2019 | A1 |
20190117070 | Muhsin et al. | Apr 2019 | A1 |
20190200941 | Chandran et al. | Jul 2019 | A1 |
20190239787 | Pauley et al. | Aug 2019 | A1 |
20190320906 | Olsen | Oct 2019 | A1 |
20190374139 | Kiani et al. | Dec 2019 | A1 |
20190374713 | Kiani et al. | Dec 2019 | A1 |
20200060869 | Telfort et al. | Feb 2020 | A1 |
20200111552 | Ahmed | Apr 2020 | A1 |
20200113435 | Muhsin | Apr 2020 | A1 |
20200113488 | Al-Ali et al. | Apr 2020 | A1 |
20200113496 | Scruggs et al. | Apr 2020 | A1 |
20200113497 | Triman et al. | Apr 2020 | A1 |
20200113520 | Abdul-Hafiz et al. | Apr 2020 | A1 |
20200138288 | Al-Ali et al. | May 2020 | A1 |
20200138368 | Kiani et al. | May 2020 | A1 |
20200163597 | Dalvi et al. | May 2020 | A1 |
20200196877 | Vo et al. | Jun 2020 | A1 |
20200253474 | Muhsin et al. | Aug 2020 | A1 |
20200253544 | Belur Nagaraj et al. | Aug 2020 | A1 |
20200275841 | Telfort et al. | Sep 2020 | A1 |
20200288983 | Telfort et al. | Sep 2020 | A1 |
20200321793 | Al-Ali et al. | Oct 2020 | A1 |
20200329983 | Al-Ali et al. | Oct 2020 | A1 |
20200329984 | Al-Ali et al. | Oct 2020 | A1 |
20200329993 | Al-Ali et al. | Oct 2020 | A1 |
20200330037 | Al-Ali et al. | Oct 2020 | A1 |
20210022628 | Telfort et al. | Jan 2021 | A1 |
20210104173 | Pauley et al. | Apr 2021 | A1 |
20210113121 | Diab et al. | Apr 2021 | A1 |
20210117525 | Kiani et al. | Apr 2021 | A1 |
20210118581 | Kiani et al. | Apr 2021 | A1 |
20210121582 | Krishnamani et al. | Apr 2021 | A1 |
20210161465 | Barker et al. | Jun 2021 | A1 |
20210236729 | Kiani et al. | Aug 2021 | A1 |
20210256267 | Ranasinghe et al. | Aug 2021 | A1 |
20210256835 | Ranasinghe et al. | Aug 2021 | A1 |
20210275101 | Vo et al. | Sep 2021 | A1 |
20210290060 | Ahmed | Sep 2021 | A1 |
20210290072 | Forrest | Sep 2021 | A1 |
20210290080 | Ahmed | Sep 2021 | A1 |
20210290120 | Al-Ali | Sep 2021 | A1 |
20210290177 | Novak, Jr. | Sep 2021 | A1 |
20210290184 | Ahmed | Sep 2021 | A1 |
20210296008 | Novak, Jr. | Sep 2021 | A1 |
20210330228 | Olsen et al. | Oct 2021 | A1 |
20210386382 | Olsen et al. | Dec 2021 | A1 |
20210402110 | Pauley et al. | Dec 2021 | A1 |
20220026355 | Normand et al. | Jan 2022 | A1 |
20220039707 | Sharma et al. | Feb 2022 | A1 |
20220053892 | Al-Ali et al. | Feb 2022 | A1 |
20220071562 | Kiani | Mar 2022 | A1 |
20220096603 | Kiani et al. | Mar 2022 | A1 |
20220151521 | Krishnamani et al. | May 2022 | A1 |
20220160265 | Sankhala | May 2022 | A1 |
20220218244 | Kiani et al. | Jul 2022 | A1 |
20220287574 | Telfort et al. | Sep 2022 | A1 |
20220296161 | Al-Ali et al. | Sep 2022 | A1 |
20220361819 | Al-Ali et al. | Nov 2022 | A1 |
20220379059 | Yu et al. | Dec 2022 | A1 |
20220392610 | Kiani et al. | Dec 2022 | A1 |
20230028745 | Al-Ali | Jan 2023 | A1 |
20230038389 | Vo | Feb 2023 | A1 |
20230045647 | Vo | Feb 2023 | A1 |
20230058052 | Al-Ali | Feb 2023 | A1 |
20230058342 | Kiani | Feb 2023 | A1 |
20230069789 | Koo et al. | Mar 2023 | A1 |
20230087671 | Telfort et al. | Mar 2023 | A1 |
20230110152 | Forrest et al. | Apr 2023 | A1 |
20230111198 | Yu et al. | Apr 2023 | A1 |
20230115397 | Vo et al. | Apr 2023 | A1 |
20230116371 | Mills et al. | Apr 2023 | A1 |
Entry |
---|
10Gbps DualBand InGaAs PIN Photodiode, Global Communication Semiconductors, Mar. 2012, in 2 pages. |
Standard InGaAs Photodiodes IG17-Series, Laser Components, V2, Aug. 2014, in 11 pages. |
Number | Date | Country | |
---|---|---|---|
20220022751 A1 | Jan 2022 | US |
Number | Date | Country | |
---|---|---|---|
62052420 | Sep 2014 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16743864 | Jan 2020 | US |
Child | 17394147 | US | |
Parent | 16505364 | Jul 2019 | US |
Child | 16743864 | US | |
Parent | 14858639 | Sep 2015 | US |
Child | 16505364 | US |